data_6l7z_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6l7z _Structure_validation_residue.Date_analyzed 2020-10-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.856 0.36 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 . . . . . 0 C--O 1.237 0.434 0 N-CA-C 111.336 0.125 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.858 0.361 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 121.283 0.563 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.328 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.387 0.137 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.223 0.058 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.299 0.095 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.238 0.485 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -103.86 -2.52 26.13 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -135.81 141.01 44.67 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.12 103.52 54.49 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 139.67 28.3 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 121.951 1.767 . . . . 0.0 111.28 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -63.63 -50.61 68.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.168 0.508 . . . . 0.0 110.015 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 178.28 128.82 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.236 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m 58.54 119.6 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 110.734 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p -89.76 25.79 1.95 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.431 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.59 131.58 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -109.53 -23.16 11.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.71 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.52 -130.63 51.27 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.16 159.45 85.38 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.36 152.54 78.88 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.891 1.727 . . . . 0.0 111.577 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtt 62.94 39.74 10.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.346 0.593 . . . . 0.0 110.054 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -56.11 121.8 10.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.873 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.32 -53.45 8.89 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -74.26 -46.68 39.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.511 0.196 . . . . 0.0 111.318 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.49 98.93 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.94 -40.27 99.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.05 -44.52 97.27 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.521 -0.34 . . . . 0.0 111.336 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 t0 62.7 142.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.983 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.73 137.55 46.48 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.825 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt -122.04 102.29 40.83 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 155.87 29.48 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.204 1.936 . . . . 0.0 111.392 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.77 -50.61 72.76 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? 179.7 127.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.704 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m 59.49 138.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.604 0.565 . . . . 0.0 110.969 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -89.0 31.37 0.87 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.37 139.39 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -123.37 129.64 51.58 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.868 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.2 -118.59 2.96 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.27 164.57 59.98 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.265 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.41 -37.12 50.36 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.952 1.768 . . . . 0.0 112.194 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.2 ttp -84.47 112.64 20.56 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -90.07 85.71 6.38 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.037 0.446 . . . . 0.0 110.611 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -41.75 99.81 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.279 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -95.28 -51.92 4.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.822 0.344 . . . . 0.0 111.884 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.16 98.2 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.113 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 -42.71 99.84 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -72.09 -39.87 68.62 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mmt . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -61.31 -43.69 98.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.52 147.26 49.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.18 103.39 54.51 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.46 142.27 26.32 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.744 1.629 . . . . 0.0 110.945 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.01 -47.53 77.17 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.301 0.572 . . . . 0.0 110.44 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 179.88 126.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 54.2 p 55.28 157.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.679 0.612 . . . . 0.0 110.907 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -118.33 28.55 8.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.28 156.35 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -64.21 -35.53 81.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.306 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.12 -130.74 49.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.59 148.18 90.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.694 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.12 145.84 97.55 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.091 1.861 . . . . 0.0 112.29 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt 61.8 30.99 18.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.878 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -174.83 79.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.65 39.61 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.571 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -57.2 -17.5 11.58 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.84 8.93 61.54 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 -0.85 18.48 Favored Glycine 0 CA--C 1.551 2.291 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -117.92 -51.82 2.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -85.26 -177.57 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.913 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.89 143.31 39.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp -120.47 103.47 44.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.42 149.88 45.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.993 1.795 . . . . 0.0 111.899 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.33 -47.35 86.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -160.56 129.15 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.736 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t 41.81 -165.01 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 O-C-N 123.476 0.485 . . . . 0.0 111.505 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t -134.6 28.81 3.6 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.38 120.76 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -127.35 130.44 49.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.205 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.9 138.49 10.61 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp 60.53 157.08 0.11 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.343 0.257 . . . . 0.0 110.931 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.85 149.56 77.39 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.188 1.925 . . . . 0.0 111.281 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.6 mtp 66.55 81.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -50.04 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.51 98.75 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.87 -39.07 16.16 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.614 0.245 . . . . 0.0 111.182 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.36 98.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.55 -40.5 98.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -63.72 -41.14 98.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 62.67 -90.62 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.063 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.92 151.35 51.47 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.61 158.78 56.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -12.48 129.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 125.3 4.0 . . . . 0.0 116.496 -170.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -86.56 -9.84 55.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.488 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -92.1 140.45 29.62 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 m 75.7 27.72 0.97 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.42 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -91.23 39.13 0.99 Allowed 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.67 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -56.66 115.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -69.99 -37.36 75.71 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.43 -132.92 43.0 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.93 156.82 86.09 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.673 -0.264 . . . . 0.0 110.594 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.27 -23.66 75.46 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.014 1.809 . . . . 0.0 112.284 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.8 mtt -62.57 -39.68 94.45 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 55.77 52.83 10.24 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.364 0.602 . . . . 0.0 110.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.74 99.59 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.07 -46.53 7.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.545 0.212 . . . . 0.0 111.463 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.83 99.69 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.98 -41.68 99.68 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 -64.6 -41.22 96.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.596 -0.302 . . . . 0.0 111.649 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 p30 -84.96 -179.19 7.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.23 143.47 50.93 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.123 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.69 104.66 55.2 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.69 146.99 21.62 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.978 1.785 . . . . 0.0 111.686 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.32 -46.87 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -173.04 128.8 0.47 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.819 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.64 -171.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.309 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -135.0 30.38 3.35 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.11 122.91 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 50.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.692 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -46.15 94.43 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp 57.14 137.56 0.03 OUTLIER Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.61 -37.06 73.85 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.719 1.613 . . . . 0.0 110.808 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -136.72 71.11 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 110.802 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pm0 -43.86 109.87 0.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.017 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.58 -41.62 96.01 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.026 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.79 -38.56 11.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.708 0.289 . . . . 0.0 110.758 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.21 95.15 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.6 97.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.43 -41.66 93.29 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.78 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 t0 67.69 -70.15 0.13 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.32 139.51 40.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.5 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.4 101.12 44.5 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -80.89 147.12 16.74 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.158 1.906 . . . . 0.0 111.4 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -63.92 -42.06 97.48 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.827 0.346 . . . . 0.0 110.266 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -171.18 128.25 0.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.6 p 47.2 -173.03 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.275 0.36 . . . . 0.0 111.218 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -134.64 42.1 2.85 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.82 139.8 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -148.41 153.53 38.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.494 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.35 179.46 48.59 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt 58.6 164.06 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.613 -0.232 . . . . 0.0 110.809 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.9 -37.49 85.55 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.114 1.876 . . . . 0.0 111.322 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.0 ttt -125.42 129.35 49.69 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.928 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.92 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.29 -41.06 99.74 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -93.71 -36.89 12.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.643 0.259 . . . . 0.0 111.084 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.95 -39.28 96.78 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.86 98.55 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -70.71 -43.45 68.96 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.317 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttp . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.12 -39.88 91.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.991 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -132.46 150.76 52.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.97 104.06 55.65 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 135.94 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.728 1.619 . . . . 0.0 111.674 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.67 -44.28 78.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.418 0.628 . . . . 0.0 109.937 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -145.19 -177.91 5.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.972 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.6 m -48.12 139.99 7.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -81.56 28.91 0.38 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -72.73 122.3 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -135.87 160.83 37.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.807 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.84 130.48 10.22 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.52 -48.08 87.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.48 -41.3 73.4 Favored 'Trans proline' 0 N--CA 1.511 2.506 0 C-N-CA 121.855 1.703 . . . . 0.0 112.554 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 80.0 mtm -141.56 146.95 36.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -90.4 24.0 2.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.22 98.45 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.86 -52.7 13.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.95 95.44 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.48 99.42 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 -60.39 -47.56 85.54 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.846 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.76 -41.59 97.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.183 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -134.45 147.51 50.42 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.09 104.0 50.27 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.01 146.08 20.05 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.096 1.864 . . . . 0.0 111.931 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.7 -25.06 23.65 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.451 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -168.05 -174.84 2.47 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -48.12 151.52 0.98 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p -88.63 36.31 0.79 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.28 156.68 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p 50.43 76.72 0.14 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.776 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.81 -19.43 1.82 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.774 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -48.71 95.59 Favored Pre-proline 0 CA--C 1.564 1.488 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.896 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.55 76.22 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.78 1.653 . . . . 0.0 112.807 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm 56.24 27.35 11.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.58 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.48 44.5 9.79 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.14 98.33 Favored Glycine 0 N--CA 1.465 0.586 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.09 -44.54 7.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.535 0.207 . . . . 0.0 111.119 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.32 99.73 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.4 98.69 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.96 -44.6 97.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.026 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.62 143.67 2.78 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.76 149.3 52.29 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.223 0.327 . . . . 0.0 110.268 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp -114.55 103.12 55.08 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.42 154.73 24.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.256 1.971 . . . . 0.0 111.579 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -62.97 -42.3 99.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.013 0.435 . . . . 0.0 110.015 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -174.99 129.61 0.3 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.22 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t 42.62 -163.75 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 O-C-N 123.42 0.45 . . . . 0.0 111.172 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -133.69 30.31 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.99 156.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -132.78 151.49 51.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.7 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.88 127.44 9.25 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt -61.08 -50.8 82.9 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.765 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 -69.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.676 1.584 . . . . 0.0 114.229 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.1 mmt -142.81 16.92 1.97 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.84 54.93 5.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.276 0.56 . . . . 0.0 110.294 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.19 98.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.674 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.37 -42.78 8.33 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.816 0.341 . . . . 0.0 111.29 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.01 97.99 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.06 -40.39 98.45 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -64.18 -41.14 97.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' THR . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 10' ' ' LEU . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 116' ' ' ALA . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 88' ' ' VAL . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.65 ' O ' HG22 ' A' ' 88' ' ' VAL . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 113' ' ' LEU . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HG22 ' A' ' 5' ' ' VAL . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.6 tt . . . . . 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.856 0.36 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD21 ' A' ' 83' ' ' LEU . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 . . . . . 0 C--O 1.237 0.434 0 N-CA-C 111.336 0.125 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.601 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 49' ' ' ILE . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 20' ' ' ALA . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.55 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.55 ' HB2' HE22 ' A' ' 89' ' ' GLN . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' CG2' HG12 ' A' ' 5' ' ' VAL . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 22' ' ' LEU . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 88' ' ' VAL . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 26' ' ' LEU . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 113' ' ' LEU . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.858 0.361 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 82' ' ' ALA . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 78' ' ' GLU . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HB2' HG22 ' A' ' 76' ' ' THR . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.537 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG23 ' CG2' ' A' ' 88' ' ' VAL . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 20' ' ' ALA . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.525 ' CD1' HD13 ' A' ' 113' ' ' LEU . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 96' ' ' TYR . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 14' ' ' ALA . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG11 ' SG ' ' A' ' 98' ' ' CYS . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 111' ' ' VAL . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.546 HD12 ' CD2' ' A' ' 113' ' ' LEU . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 116' ' ' ALA . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.691 ' C ' HG13 ' A' ' 115' ' ' VAL . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 ' HA ' HG13 ' A' ' 88' ' ' VAL . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 88' ' ' VAL . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 113' ' ' LEU . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.456 ' NE2' ' OG ' ' A' ' 80' ' ' SER . 29.0 mm100 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 81' ' ' VAL . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.0 mp . . . . . 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 48' ' ' VAL . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 41' ' ' ARG . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG21 HD21 ' A' ' 83' ' ' LEU . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.456 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 26' ' ' LEU . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 49' ' ' ILE . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 20' ' ' ALA . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 18' ' ' GLU . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 88' ' ' VAL . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.472 ' CG ' HD23 ' A' ' 112' ' ' LEU . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.486 ' CE2' HD13 ' A' ' 113' ' ' LEU . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.471 ' SG ' HG11 ' A' ' 5' ' ' VAL . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.452 ' HE1' HD13 ' A' ' 26' ' ' LEU . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 113' ' ' LEU . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 95' ' ' GLN . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 22' ' ' LEU . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 14' ' ' ALA . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 109' ' ' THR . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 10' ' ' LEU . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.707 ' O ' HG12 ' A' ' 88' ' ' VAL . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.917 HD11 ' HB1' ' A' ' 82' ' ' ALA . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 83' ' ' LEU . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.9 p . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.917 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 49' ' ' ILE . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 20' ' ' ALA . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 18' ' ' GLU . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.531 ' HB2' HE22 ' A' ' 89' ' ' GLN . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.623 ' HB2' HG22 ' A' ' 115' ' ' VAL . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.654 ' CD1' HD11 ' A' ' 113' ' ' LEU . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 7' ' ' GLY . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 93' ' ' ASP . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 6' ' ' VAL . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 4' ' ' ARG . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 110' ' ' SER . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.422 ' HB ' HD22 ' A' ' 113' ' ' LEU . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 116' ' ' ALA . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 82' ' ' ALA . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 113' ' ' LEU . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 81' ' ' VAL . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 121.283 0.563 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 78' ' ' GLU . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 76' ' ' THR . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 26' ' ' LEU . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 115' ' ' VAL . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.549 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.445 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.402 ' HD2' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 113' ' ' LEU . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 22' ' ' LEU . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 88' ' ' VAL . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 98' ' ' CYS . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 89' ' ' GLN . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.437 ' O ' HG11 ' A' ' 111' ' ' VAL . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 81' ' ' VAL . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.8 tt . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH2' HD11 ' A' ' 85' ' ' ILE . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.328 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 78' ' ' GLU . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 76' ' ' THR . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.473 HD11 ' NH2' ' A' ' 41' ' ' ARG . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 20' ' ' ALA . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 115' ' ' VAL . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 96' ' ' TYR . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 96' ' ' TYR . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG11 ' CG1' ' A' ' 88' ' ' VAL . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 98' ' ' CYS . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG12 ' HD3' ' A' ' 8' ' ' PRO . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD3' HG12 ' A' ' 6' ' ' VAL . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 10' ' ' LEU . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' HD12 ' A' ' 10' ' ' LEU . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 89' ' ' GLN . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 82' ' ' ALA . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.621 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 20' ' ' ALA . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' HG11 ' A' ' 5' ' ' VAL . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 4.9 tm0? -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' NE2' ' A' ' 101' ' ' GLN . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 22' ' ' LEU . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG11 ' CG1' ' A' ' 88' ' ' VAL . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.387 0.137 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 25' ' ' GLN . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 113' ' ' LEU . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 13' ' ' LEU . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 88' ' ' VAL . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.603 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 12' ' ' ILE . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 5' ' ' VAL . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 ' CH2' ' A' ' 39' ' ' TRP . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.505 ' CH2' HG23 ' A' ' 37' ' ' VAL . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 57' ' ' VAL . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.61 ' O ' HD11 ' A' ' 49' ' ' ILE . 86.7 t . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.223 0.058 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 49' ' ' ILE . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 18' ' ' GLU . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' HE22 ' A' ' 89' ' ' GLN . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 106' ' ' TRP . 10.8 tp-100 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.447 ' HB3' ' NE2' ' A' ' 101' ' ' GLN . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.543 ' NH1' HG22 ' A' ' 6' ' ' VAL . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 109' ' ' THR . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HD3' ' A' ' 8' ' ' PRO . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' HG12 ' A' ' 6' ' ' VAL . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' HD13 ' A' ' 112' ' ' LEU . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 113' ' ' LEU . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HG12 ' A' ' 88' ' ' VAL . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HB1' ' A' ' 82' ' ' ALA . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 113' ' ' LEU . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 81' ' ' VAL . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HE ' HG21 ' A' ' 48' ' ' VAL . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 HG21 ' HE ' ' A' ' 41' ' ' ARG . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.299 0.095 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 83' ' ' LEU . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 78' ' ' GLU . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 76' ' ' THR . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 26' ' ' LEU . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' NE2' ' OG ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.442 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 88' ' ' VAL . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 5' ' ' VAL . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 5' ' ' VAL . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.405 HD13 ' HD3' ' A' ' 11' ' ' PRO . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 22' ' ' LEU . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.654 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.238 0.485 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.565 ' O ' HG21 ' A' ' 109' ' ' THR . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' A' ' 111' ' ' VAL . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.654 ' O ' HG12 ' A' ' 88' ' ' VAL . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.824 ' O ' HD21 ' A' ' 113' ' ' LEU . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.1 HD23 HD22 ' A' ' 113' ' ' LEU . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 26' ' ' LEU . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.498 HG21 HD21 ' A' ' 83' ' ' LEU . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.949 HD11 ' HB1' ' A' ' 69' ' ' ALA . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.524 ' N ' HD13 ' A' ' 85' ' ' ILE . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 115' ' ' VAL . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.448 ' NE2' ' OG ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.448 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 5' ' ' VAL . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 5' ' ' VAL . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 9' ' ' ASN . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.1 HD22 HD23 ' A' ' 22' ' ' LEU . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.79 HG11 HG21 ' A' ' 88' ' ' VAL . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -103.86 -2.52 26.13 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -135.81 141.01 44.67 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' THR . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 10' ' ' LEU . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 116' ' ' ALA . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 88' ' ' VAL . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.65 ' O ' HG22 ' A' ' 88' ' ' VAL . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 113' ' ' LEU . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HG22 ' A' ' 5' ' ' VAL . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.6 tt -115.12 103.52 54.49 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 139.67 28.3 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 121.951 1.767 . . . . 0.0 111.28 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -63.63 -50.61 68.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.168 0.508 . . . . 0.0 110.015 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 178.28 128.82 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.236 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m 58.54 119.6 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 110.734 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p -89.76 25.79 1.95 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.431 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD21 ' A' ' 83' ' ' LEU . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.59 131.58 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -109.53 -23.16 11.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.71 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.52 -130.63 51.27 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 60' ' ' LEU . 4.5 pp -72.16 159.45 85.38 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.118 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.36 152.54 78.88 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.891 1.727 . . . . 0.0 111.577 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtt 62.94 39.74 10.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.346 0.593 . . . . 0.0 110.054 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -56.11 121.8 10.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.873 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.32 -53.45 8.89 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -74.26 -46.68 39.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.511 0.196 . . . . 0.0 111.318 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.49 98.93 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.94 -40.27 99.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.05 -44.52 97.27 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.521 -0.34 . . . . 0.0 111.336 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.601 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 49' ' ' ILE . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 20' ' ' ALA . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.55 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.55 ' HB2' HE22 ' A' ' 89' ' ' GLN . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' CG2' HG12 ' A' ' 5' ' ' VAL . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 22' ' ' LEU . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 88' ' ' VAL . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 t0 62.7 142.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.983 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.73 137.55 46.48 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.825 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 26' ' ' LEU . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 113' ' ' LEU . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt -122.04 102.29 40.83 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 155.87 29.48 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.204 1.936 . . . . 0.0 111.392 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.77 -50.61 72.76 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? 179.7 127.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.704 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m 59.49 138.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.604 0.565 . . . . 0.0 110.969 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -89.0 31.37 0.87 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.37 139.39 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -123.37 129.64 51.58 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.868 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.2 -118.59 2.96 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.27 164.57 59.98 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.265 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.41 -37.12 50.36 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.952 1.768 . . . . 0.0 112.194 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.2 ttp -84.47 112.64 20.56 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -90.07 85.71 6.38 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.037 0.446 . . . . 0.0 110.611 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -41.75 99.81 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.279 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -95.28 -51.92 4.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.822 0.344 . . . . 0.0 111.884 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.16 98.2 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.113 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 -42.71 99.84 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -72.09 -39.87 68.62 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 82' ' ' ALA . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 78' ' ' GLU . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HB2' HG22 ' A' ' 76' ' ' THR . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.537 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG23 ' CG2' ' A' ' 88' ' ' VAL . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 20' ' ' ALA . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.525 ' CD1' HD13 ' A' ' 113' ' ' LEU . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 96' ' ' TYR . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 14' ' ' ALA . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mmt . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -61.31 -43.69 98.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.52 147.26 49.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG11 ' SG ' ' A' ' 98' ' ' CYS . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 111' ' ' VAL . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.546 HD12 ' CD2' ' A' ' 113' ' ' LEU . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 116' ' ' ALA . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.691 ' C ' HG13 ' A' ' 115' ' ' VAL . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 ' HA ' HG13 ' A' ' 88' ' ' VAL . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 88' ' ' VAL . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 113' ' ' LEU . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.456 ' NE2' ' OG ' ' A' ' 80' ' ' SER . 29.0 mm100 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 81' ' ' VAL . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.0 mp -115.18 103.39 54.51 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.46 142.27 26.32 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.744 1.629 . . . . 0.0 110.945 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.01 -47.53 77.17 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.301 0.572 . . . . 0.0 110.44 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' HG23 ' A' ' 31' ' ' THR . 80.5 ttt180 179.88 126.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 30' ' ' ARG . 54.2 p 55.28 157.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.679 0.612 . . . . 0.0 110.907 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -118.33 28.55 8.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 48' ' ' VAL . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 41' ' ' ARG . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG21 HD21 ' A' ' 83' ' ' LEU . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.28 156.35 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -64.21 -35.53 81.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.306 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.12 -130.74 49.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.59 148.18 90.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.694 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.12 145.84 97.55 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.091 1.861 . . . . 0.0 112.29 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt 61.8 30.99 18.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.878 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -174.83 79.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.65 39.61 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.571 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -57.2 -17.5 11.58 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.84 8.93 61.54 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 -0.85 18.48 Favored Glycine 0 CA--C 1.551 2.291 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -117.92 -51.82 2.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.456 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 26' ' ' LEU . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 49' ' ' ILE . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 20' ' ' ALA . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 18' ' ' GLU . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 88' ' ' VAL . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' CG ' HD23 ' A' ' 112' ' ' LEU . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.486 ' CE2' HD13 ' A' ' 113' ' ' LEU . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.471 ' SG ' HG11 ' A' ' 5' ' ' VAL . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.452 ' HE1' HD13 ' A' ' 26' ' ' LEU . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 113' ' ' LEU . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 95' ' ' GLN . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 22' ' ' LEU . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 14' ' ' ALA . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -85.26 -177.57 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.913 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.89 143.31 39.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 109' ' ' THR . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 10' ' ' LEU . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.707 ' O ' HG12 ' A' ' 88' ' ' VAL . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.917 HD11 ' HB1' ' A' ' 82' ' ' ALA . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp -120.47 103.47 44.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.42 149.88 45.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.993 1.795 . . . . 0.0 111.899 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.33 -47.35 86.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -160.56 129.15 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.736 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t 41.81 -165.01 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 O-C-N 123.476 0.485 . . . . 0.0 111.505 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t -134.6 28.81 3.6 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 83' ' ' LEU . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.9 p -73.38 120.76 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -127.35 130.44 49.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.205 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.9 138.49 10.61 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp 60.53 157.08 0.11 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.343 0.257 . . . . 0.0 110.931 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.85 149.56 77.39 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.188 1.925 . . . . 0.0 111.281 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.6 mtp 66.55 81.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -50.04 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.51 98.75 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.87 -39.07 16.16 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.614 0.245 . . . . 0.0 111.182 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.36 98.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.55 -40.5 98.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -63.72 -41.14 98.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.917 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 49' ' ' ILE . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 20' ' ' ALA . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 18' ' ' GLU . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.531 ' HB2' HE22 ' A' ' 89' ' ' GLN . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.623 ' HB2' HG22 ' A' ' 115' ' ' VAL . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.654 ' CD1' HD11 ' A' ' 113' ' ' LEU . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 7' ' ' GLY . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 93' ' ' ASP . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 62.67 -90.62 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.063 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.92 151.35 51.47 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 6' ' ' VAL . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 4' ' ' ARG . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 110' ' ' SER . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.422 ' HB ' HD22 ' A' ' 113' ' ' LEU . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 116' ' ' ALA . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 82' ' ' ALA . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 113' ' ' LEU . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 81' ' ' VAL . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.61 158.78 56.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -12.48 129.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 125.3 4.0 . . . . 0.0 116.496 -170.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -86.56 -9.84 55.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.488 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -92.1 140.45 29.62 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 m 75.7 27.72 0.97 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.42 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -91.23 39.13 0.99 Allowed 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.67 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.1 p -56.66 115.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -69.99 -37.36 75.71 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.43 -132.92 43.0 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 60' ' ' LEU . 3.6 mm? -74.93 156.82 86.09 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.673 -0.264 . . . . 0.0 110.594 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.27 -23.66 75.46 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.014 1.809 . . . . 0.0 112.284 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.8 mtt -62.57 -39.68 94.45 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 55.77 52.83 10.24 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.364 0.602 . . . . 0.0 110.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.74 99.59 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.07 -46.53 7.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.545 0.212 . . . . 0.0 111.463 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.83 99.69 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.98 -41.68 99.68 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 -64.6 -41.22 96.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.596 -0.302 . . . . 0.0 111.649 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 78' ' ' GLU . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 76' ' ' THR . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 26' ' ' LEU . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 115' ' ' VAL . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.549 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.445 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.402 ' HD2' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 113' ' ' LEU . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 22' ' ' LEU . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 88' ' ' VAL . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 p30 -84.96 -179.19 7.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.23 143.47 50.93 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.123 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 98' ' ' CYS . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 89' ' ' GLN . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.437 ' O ' HG11 ' A' ' 111' ' ' VAL . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 81' ' ' VAL . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.8 tt -113.69 104.66 55.2 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.69 146.99 21.62 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.978 1.785 . . . . 0.0 111.686 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.32 -46.87 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -173.04 128.8 0.47 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.819 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.64 -171.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.309 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -135.0 30.38 3.35 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH2' HD11 ' A' ' 85' ' ' ILE . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.11 122.91 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 50.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.692 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -46.15 94.43 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp 57.14 137.56 0.03 OUTLIER Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.61 -37.06 73.85 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.719 1.613 . . . . 0.0 110.808 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -136.72 71.11 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 110.802 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pm0 -43.86 109.87 0.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.017 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.58 -41.62 96.01 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.026 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.79 -38.56 11.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.708 0.289 . . . . 0.0 110.758 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.21 95.15 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.6 97.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.43 -41.66 93.29 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.78 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 78' ' ' GLU . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 76' ' ' THR . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.473 HD11 ' NH2' ' A' ' 41' ' ' ARG . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 20' ' ' ALA . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 115' ' ' VAL . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 96' ' ' TYR . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 96' ' ' TYR . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG11 ' CG1' ' A' ' 88' ' ' VAL . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 t0 67.69 -70.15 0.13 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.32 139.51 40.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.5 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 98' ' ' CYS . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG12 ' HD3' ' A' ' 8' ' ' PRO . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD3' HG12 ' A' ' 6' ' ' VAL . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 ' C ' HD12 ' A' ' 10' ' ' LEU . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' HD12 ' A' ' 10' ' ' LEU . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 89' ' ' GLN . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 82' ' ' ALA . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 HD12 ' HD3' ' A' ' 28' ' ' PRO . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.4 101.12 44.5 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' HD12 ' A' ' 26' ' ' LEU . 79.8 Cg_endo -80.89 147.12 16.74 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.158 1.906 . . . . 0.0 111.4 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -63.92 -42.06 97.48 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.827 0.346 . . . . 0.0 110.266 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -171.18 128.25 0.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.6 p 47.2 -173.03 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.275 0.36 . . . . 0.0 111.218 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -134.64 42.1 2.85 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.82 139.8 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -148.41 153.53 38.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.494 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.35 179.46 48.59 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt 58.6 164.06 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.613 -0.232 . . . . 0.0 110.809 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.9 -37.49 85.55 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.114 1.876 . . . . 0.0 111.322 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.0 ttt -125.42 129.35 49.69 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.928 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.92 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.29 -41.06 99.74 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -93.71 -36.89 12.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.643 0.259 . . . . 0.0 111.084 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.95 -39.28 96.78 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.86 98.55 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -70.71 -43.45 68.96 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.317 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.621 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 20' ' ' ALA . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' HG11 ' A' ' 5' ' ' VAL . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 4.9 tm0? -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' NE2' ' A' ' 101' ' ' GLN . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 22' ' ' LEU . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG11 ' CG1' ' A' ' 88' ' ' VAL . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttp . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.12 -39.88 91.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.991 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -132.46 150.76 52.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 25' ' ' GLN . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 113' ' ' LEU . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 13' ' ' LEU . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 88' ' ' VAL . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.603 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 12' ' ' ILE . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 5' ' ' VAL . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.97 104.06 55.65 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 135.94 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.728 1.619 . . . . 0.0 111.674 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.67 -44.28 78.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.418 0.628 . . . . 0.0 109.937 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -145.19 -177.91 5.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.972 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.6 m -48.12 139.99 7.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -81.56 28.91 0.38 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 ' CH2' ' A' ' 39' ' ' TRP . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.505 ' CH2' HG23 ' A' ' 37' ' ' VAL . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 57' ' ' VAL . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.61 ' O ' HD11 ' A' ' 49' ' ' ILE . 86.7 t -72.73 122.3 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -135.87 160.83 37.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.807 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.84 130.48 10.22 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 60' ' ' LEU . 8.5 mp -62.52 -48.08 87.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.48 -41.3 73.4 Favored 'Trans proline' 0 N--CA 1.511 2.506 0 C-N-CA 121.855 1.703 . . . . 0.0 112.554 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 80.0 mtm -141.56 146.95 36.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -90.4 24.0 2.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.22 98.45 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.86 -52.7 13.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.95 95.44 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.48 99.42 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 -60.39 -47.56 85.54 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.846 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 49' ' ' ILE . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 18' ' ' GLU . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' A' ' 91' ' ' SER . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' HE22 ' A' ' 89' ' ' GLN . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 106' ' ' TRP . 10.8 tp-100 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.447 ' HB3' ' NE2' ' A' ' 101' ' ' GLN . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.76 -41.59 97.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.183 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -134.45 147.51 50.42 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.543 ' NH1' HG22 ' A' ' 6' ' ' VAL . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 109' ' ' THR . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HD3' ' A' ' 8' ' ' PRO . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' HG12 ' A' ' 6' ' ' VAL . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' HD13 ' A' ' 112' ' ' LEU . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 113' ' ' LEU . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HG12 ' A' ' 88' ' ' VAL . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HB1' ' A' ' 82' ' ' ALA . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 113' ' ' LEU . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 81' ' ' VAL . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.09 104.0 50.27 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.01 146.08 20.05 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.096 1.864 . . . . 0.0 111.931 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.7 -25.06 23.65 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.451 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -168.05 -174.84 2.47 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -48.12 151.52 0.98 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p -88.63 36.31 0.79 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HE ' HG21 ' A' ' 48' ' ' VAL . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 HG21 ' HE ' ' A' ' 41' ' ' ARG . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.28 156.68 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p 50.43 76.72 0.14 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.776 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.81 -19.43 1.82 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.774 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -59.28 -48.71 95.59 Favored Pre-proline 0 CA--C 1.564 1.488 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.896 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.55 76.22 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.78 1.653 . . . . 0.0 112.807 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm 56.24 27.35 11.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.58 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.48 44.5 9.79 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.14 98.33 Favored Glycine 0 N--CA 1.465 0.586 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.09 -44.54 7.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.535 0.207 . . . . 0.0 111.119 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.32 99.73 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.4 98.69 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.96 -44.6 97.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.026 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 83' ' ' LEU . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 78' ' ' GLU . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 76' ' ' THR . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 26' ' ' LEU . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' NE2' ' OG ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.442 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 88' ' ' VAL . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 5' ' ' VAL . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 5' ' ' VAL . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.405 HD13 ' HD3' ' A' ' 11' ' ' PRO . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 22' ' ' LEU . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.654 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.62 143.67 2.78 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.76 149.3 52.29 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.223 0.327 . . . . 0.0 110.268 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 ' O ' HG21 ' A' ' 109' ' ' THR . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' A' ' 111' ' ' VAL . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.654 ' O ' HG12 ' A' ' 88' ' ' VAL . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.824 ' O ' HD21 ' A' ' 113' ' ' LEU . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.1 HD23 HD22 ' A' ' 113' ' ' LEU . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 26' ' ' LEU . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp -114.55 103.12 55.08 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.42 154.73 24.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.256 1.971 . . . . 0.0 111.579 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -62.97 -42.3 99.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.013 0.435 . . . . 0.0 110.015 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -174.99 129.61 0.3 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.22 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t 42.62 -163.75 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 O-C-N 123.42 0.45 . . . . 0.0 111.172 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -133.69 30.31 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.498 HG21 HD21 ' A' ' 83' ' ' LEU . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.99 156.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -132.78 151.49 51.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.7 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.88 127.44 9.25 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 60' ' ' LEU . 5.1 tt -61.08 -50.8 82.9 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.765 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 -69.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.676 1.584 . . . . 0.0 114.229 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.1 mmt -142.81 16.92 1.97 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.84 54.93 5.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.276 0.56 . . . . 0.0 110.294 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.19 98.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.674 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.37 -42.78 8.33 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.816 0.341 . . . . 0.0 111.29 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.01 97.99 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.06 -40.39 98.45 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -64.18 -41.14 97.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.949 HD11 ' HB1' ' A' ' 69' ' ' ALA . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.524 ' N ' HD13 ' A' ' 85' ' ' ILE . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 115' ' ' VAL . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.448 ' NE2' ' OG ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.448 ' OG ' ' NE2' ' A' ' 89' ' ' GLN . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 5' ' ' VAL . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 5' ' ' VAL . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 9' ' ' ASN . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.1 HD22 HD23 ' A' ' 22' ' ' LEU . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.79 HG11 HG21 ' A' ' 88' ' ' VAL . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' THR . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 10' ' ' LEU . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 116' ' ' ALA . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 88' ' ' VAL . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.65 ' O ' HG22 ' A' ' 88' ' ' VAL . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 113' ' ' LEU . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HG22 ' A' ' 5' ' ' VAL . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 27' ' ' LEU . 6.6 tt . . . . . 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.244 0.798 0 CA-C-O 120.856 0.36 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD21 ' A' ' 83' ' ' LEU . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 . . . . . 0 C--O 1.237 0.434 0 N-CA-C 111.336 0.125 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.601 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 49' ' ' ILE . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 20' ' ' ALA . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' CG2' HG12 ' A' ' 5' ' ' VAL . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 22' ' ' LEU . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 88' ' ' VAL . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 26' ' ' LEU . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 113' ' ' LEU . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.858 0.361 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 82' ' ' ALA . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 78' ' ' GLU . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HB2' HG22 ' A' ' 76' ' ' THR . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.537 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG23 ' CG2' ' A' ' 88' ' ' VAL . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 20' ' ' ALA . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.525 ' CD1' HD13 ' A' ' 113' ' ' LEU . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 96' ' ' TYR . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 14' ' ' ALA . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG11 ' SG ' ' A' ' 98' ' ' CYS . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 111' ' ' VAL . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.546 HD12 ' CD2' ' A' ' 113' ' ' LEU . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 116' ' ' ALA . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.691 ' C ' HG13 ' A' ' 115' ' ' VAL . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 ' HA ' HG13 ' A' ' 88' ' ' VAL . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 88' ' ' VAL . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 113' ' ' LEU . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 81' ' ' VAL . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.0 mp . . . . . 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 48' ' ' VAL . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 41' ' ' ARG . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG21 HD21 ' A' ' 83' ' ' LEU . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 26' ' ' LEU . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 49' ' ' ILE . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 20' ' ' ALA . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 18' ' ' GLU . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 88' ' ' VAL . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.472 ' CG ' HD23 ' A' ' 112' ' ' LEU . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.486 ' CE2' HD13 ' A' ' 113' ' ' LEU . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.471 ' SG ' HG11 ' A' ' 5' ' ' VAL . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.452 ' HE1' HD13 ' A' ' 26' ' ' LEU . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 113' ' ' LEU . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 95' ' ' GLN . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 22' ' ' LEU . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 14' ' ' ALA . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 109' ' ' THR . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 10' ' ' LEU . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.707 ' O ' HG12 ' A' ' 88' ' ' VAL . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.917 HD11 ' HB1' ' A' ' 82' ' ' ALA . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 83' ' ' LEU . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.9 p . . . . . 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.917 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 49' ' ' ILE . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 20' ' ' ALA . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 18' ' ' GLU . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.451 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.623 ' HB2' HG22 ' A' ' 115' ' ' VAL . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.654 ' CD1' HD11 ' A' ' 113' ' ' LEU . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 7' ' ' GLY . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 93' ' ' ASP . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 6' ' ' VAL . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 4' ' ' ARG . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 110' ' ' SER . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.422 ' HB ' HD22 ' A' ' 113' ' ' LEU . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 116' ' ' ALA . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 82' ' ' ALA . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 113' ' ' LEU . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 81' ' ' VAL . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 121.283 0.563 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.1 p . . . . . 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 78' ' ' GLU . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 76' ' ' THR . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 26' ' ' LEU . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 115' ' ' VAL . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.549 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.402 ' HD2' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 113' ' ' LEU . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 22' ' ' LEU . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 88' ' ' VAL . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 98' ' ' CYS . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 89' ' ' GLN . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.437 ' O ' HG11 ' A' ' 111' ' ' VAL . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 81' ' ' VAL . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.8 tt . . . . . 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH2' HD11 ' A' ' 85' ' ' ILE . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.328 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 78' ' ' GLU . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 76' ' ' THR . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.473 HD11 ' NH2' ' A' ' 41' ' ' ARG . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 20' ' ' ALA . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 115' ' ' VAL . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.645 HE22 HD23 ' A' ' 112' ' ' LEU . 18.6 mm100 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 96' ' ' TYR . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.645 HD23 HE22 ' A' ' 95' ' ' GLN . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 96' ' ' TYR . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG11 ' CG1' ' A' ' 88' ' ' VAL . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 98' ' ' CYS . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG12 ' HD3' ' A' ' 8' ' ' PRO . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD3' HG12 ' A' ' 6' ' ' VAL . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 10' ' ' LEU . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' HD12 ' A' ' 10' ' ' LEU . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 89' ' ' GLN . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 82' ' ' ALA . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.621 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 20' ' ' ALA . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' HG11 ' A' ' 5' ' ' VAL . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 22' ' ' LEU . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG11 ' CG1' ' A' ' 88' ' ' VAL . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.387 0.137 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 25' ' ' GLN . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 113' ' ' LEU . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 13' ' ' LEU . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 88' ' ' VAL . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.603 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 12' ' ' ILE . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 5' ' ' VAL . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt . . . . . 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 ' CH2' ' A' ' 39' ' ' TRP . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.505 ' CH2' HG23 ' A' ' 37' ' ' VAL . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 57' ' ' VAL . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.61 ' O ' HD11 ' A' ' 49' ' ' ILE . 86.7 t . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.223 0.058 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 49' ' ' ILE . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 18' ' ' GLU . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--O 1.237 0.418 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.543 ' NH1' HG22 ' A' ' 6' ' ' VAL . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 109' ' ' THR . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HD3' ' A' ' 8' ' ' PRO . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' HG12 ' A' ' 6' ' ' VAL . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' HD13 ' A' ' 112' ' ' LEU . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 113' ' ' LEU . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HG12 ' A' ' 88' ' ' VAL . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HB1' ' A' ' 82' ' ' ALA . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 113' ' ' LEU . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 81' ' ' VAL . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HE ' HG21 ' A' ' 48' ' ' VAL . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 HG21 ' HE ' ' A' ' 41' ' ' ARG . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.299 0.095 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 83' ' ' LEU . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 78' ' ' GLU . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 76' ' ' THR . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 26' ' ' LEU . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 88' ' ' VAL . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 5' ' ' VAL . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 5' ' ' VAL . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.405 HD13 ' HD3' ' A' ' 11' ' ' PRO . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 22' ' ' LEU . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.654 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.238 0.485 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.565 ' O ' HG21 ' A' ' 109' ' ' THR . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' A' ' 111' ' ' VAL . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.654 ' O ' HG12 ' A' ' 88' ' ' VAL . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.824 ' O ' HD21 ' A' ' 113' ' ' LEU . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.1 HD23 HD22 ' A' ' 113' ' ' LEU . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 26' ' ' LEU . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp . . . . . 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.498 HG21 HD21 ' A' ' 83' ' ' LEU . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.949 HD11 ' HB1' ' A' ' 69' ' ' ALA . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.524 ' N ' HD13 ' A' ' 85' ' ' ILE . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 115' ' ' VAL . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 5' ' ' VAL . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 5' ' ' VAL . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 9' ' ' ASN . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.1 HD22 HD23 ' A' ' 22' ' ' LEU . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.79 HG11 HG21 ' A' ' 88' ' ' VAL . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -103.86 -2.52 26.13 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -135.81 141.01 44.67 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.378 0.132 . . . . 0.0 111.166 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -147.01 137.6 23.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.049 0.452 . . . . 0.0 111.592 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' THR . 62.0 t -125.43 134.62 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.934 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.5 153.5 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.784 0.326 . . . . 0.0 111.391 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.21 50.98 0.74 Allowed Glycine 0 CA--C 1.555 2.585 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.12 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.02 -8.07 22.23 Favored 'Trans proline' 0 N--CA 1.507 2.309 0 C-N-CA 122.31 2.007 . . . . 0.0 112.656 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -57.23 139.43 52.72 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 10' ' ' LEU . 7.5 mp -74.43 158.3 85.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 19.6 Cg_endo -58.0 137.06 78.95 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.633 1.555 . . . . 0.0 111.594 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.3 mm -102.15 126.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.62 109.33 20.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.017 0.437 . . . . 0.0 112.038 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.39 135.64 49.81 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.582 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HG3' ' HB3' ' A' ' 116' ' ' ALA . 2.7 mppt? -80.09 148.58 30.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.501 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 88' ' ' VAL . 8.5 p -54.87 131.24 17.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.92 -20.55 50.16 Favored Glycine 0 CA--C 1.544 1.894 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.65 ' O ' HG22 ' A' ' 88' ' ' VAL . 50.7 tp10 -98.9 151.26 21.05 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -75.88 157.38 33.34 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.229 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -121.91 162.01 21.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.941 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -120.47 105.68 11.09 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 113' ' ' LEU . 83.9 mt -80.21 132.36 35.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -148.51 145.37 27.87 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.6 p -158.22 163.32 37.59 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.998 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -110.78 125.63 53.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HG22 ' A' ' 5' ' ' VAL . 4.4 pp -133.12 154.0 51.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.715 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.6 tt -115.12 103.52 54.49 Favored Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 139.67 28.3 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 121.951 1.767 . . . . 0.0 111.28 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -63.63 -50.61 68.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.168 0.508 . . . . 0.0 110.015 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 178.28 128.82 0.06 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.236 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m 58.54 119.6 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 110.734 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.2 p -89.76 25.79 1.95 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.431 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.44 94.16 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -107.12 -2.2 21.21 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.887 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 mmt -81.65 142.99 32.24 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.748 0.308 . . . . 0.0 111.008 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -129.1 134.85 48.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.454 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.65 129.03 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -123.99 136.85 54.57 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.929 0.395 . . . . 0.0 111.862 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -114.05 140.57 48.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.124 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -122.85 138.81 54.55 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 122.969 0.168 . . . . 0.0 111.123 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -96.25 83.6 3.61 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.002 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.3 m 49.45 18.92 0.31 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.693 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.37 84.16 14.61 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 122.397 0.279 . . . . 0.0 110.997 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.68 -21.34 72.86 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.072 1.848 . . . . 0.0 112.47 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.16 -34.47 77.69 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.588 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -134.68 126.72 18.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.45 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -82.79 138.39 9.31 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.001 1.801 . . . . 0.0 111.758 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.24 -45.46 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.295 0.372 . . . . 0.0 110.258 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HD21 ' A' ' 83' ' ' LEU . 10.2 tp -159.89 151.59 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.602 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.1 ptm -131.72 152.14 51.13 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -115.04 114.74 25.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.21 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.5 147.77 47.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.758 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t0 49.97 41.06 22.51 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.045 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.05 18.53 72.93 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.624 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.11 148.37 31.52 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.55 0.675 . . . . 0.0 111.915 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -87.27 141.67 28.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.971 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.59 131.58 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.616 0.246 . . . . 0.0 111.119 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.1 p -109.53 -23.16 11.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.71 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.52 -130.63 51.27 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 60' ' ' LEU . 4.5 pp -72.16 159.45 85.38 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 119.43 -0.319 . . . . 0.0 111.118 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.36 152.54 78.88 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.891 1.727 . . . . 0.0 111.577 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtt 62.94 39.74 10.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.346 0.593 . . . . 0.0 110.054 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pm0 -56.11 121.8 10.24 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.873 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.32 -53.45 8.89 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -74.26 -46.68 39.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.511 0.196 . . . . 0.0 111.318 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.49 98.93 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.94 -40.27 99.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.05 -44.52 97.27 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.521 -0.34 . . . . 0.0 111.336 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.99 123.43 45.17 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.73 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -126.15 135.08 51.24 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.281 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -72.75 129.13 37.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.966 0.413 . . . . 0.0 112.113 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.601 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 1.9 tmt? -125.55 102.99 7.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.149 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.27 138.27 53.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.5 148.66 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.919 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.7 t -61.87 -38.36 87.99 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.763 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.7 m -58.7 -38.41 78.21 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.751 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 58.57 35.51 24.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.76 0.314 . . . . 0.0 111.506 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -108.39 48.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.633 0.73 . . . . 0.0 110.354 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.18 83.37 Favored Glycine 0 CA--C 1.541 1.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.525 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.9 p -81.52 155.52 25.72 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 117.245 0.522 . . . . 0.0 110.389 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.4 m -138.4 158.66 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -147.23 143.98 28.55 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.246 177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 49' ' ' ILE . 52.4 tp -123.22 125.45 45.11 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.825 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -91.76 122.59 34.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -114.37 128.51 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.98 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -85.48 147.68 26.34 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 52.63 73.31 0.35 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.615 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 20' ' ' ALA . 25.7 m -69.02 157.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 169.14 9.8 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.547 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.94 -34.08 27.79 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.231 1.954 . . . . 0.0 112.457 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 m -61.52 -35.97 79.22 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.169 0.293 . . . . 0.0 110.575 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.75 -36.29 83.15 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.75 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -54.34 119.9 5.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.969 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.59 -148.33 19.53 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -113.25 149.33 33.97 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.92 0.39 . . . . 0.0 111.688 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -127.97 134.39 49.27 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.494 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -102.82 129.93 49.66 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 81.9 m -89.73 139.32 30.68 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -125.74 108.54 11.61 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -92.73 114.34 26.86 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -115.82 125.64 52.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 111.602 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -151.91 132.1 13.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.628 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.11 -130.11 46.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -111.23 13.71 21.74 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -128.82 136.76 50.93 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -145.94 160.68 41.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.778 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -145.18 149.72 35.48 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.117 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -138.53 157.86 45.36 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' CG2' HG12 ' A' ' 5' ' ' VAL . 9.6 t -150.22 148.87 29.42 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.245 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.8 t -83.64 153.21 24.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.05 137.3 58.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.186 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 84.4 mt -87.19 117.16 25.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.925 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 22' ' ' LEU . 4.5 mp -134.92 115.19 13.3 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.122 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -121.11 101.77 7.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.666 0.27 . . . . 0.0 110.707 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 88' ' ' VAL . 29.7 m -81.61 137.91 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . . . -69.89 140.15 53.11 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.959 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 t0 62.7 142.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.983 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.73 137.55 46.48 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.825 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -140.68 136.29 32.49 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.04 0.448 . . . . 0.0 112.105 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 26' ' ' LEU . 27.3 m -121.96 149.93 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.012 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.37 157.66 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.91 0.386 . . . . 0.0 111.777 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.39 51.57 0.78 Allowed Glycine 0 CA--C 1.551 2.287 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.83 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.33 -9.81 25.98 Favored 'Trans proline' 0 N--CA 1.506 2.241 0 C-N-CA 122.197 1.932 . . . . 0.0 112.514 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -56.06 138.2 49.84 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.122 0.487 . . . . 0.0 111.398 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.57 158.25 83.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.379 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 84.2 Cg_exo -50.13 129.38 25.06 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.696 1.597 . . . . 0.0 111.879 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.1 mm -98.5 123.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.1 108.74 19.53 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . -108.93 -175.8 2.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.707 174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.41 145.44 50.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.474 0.178 . . . . 0.0 110.986 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.04 128.9 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.04 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.4 -16.04 59.89 Favored Glycine 0 CA--C 1.546 1.972 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -99.02 151.64 20.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -74.52 150.02 39.99 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.292 0.37 . . . . 0.0 110.666 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -126.11 160.18 30.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.748 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 20' ' ' ALA . 4.6 mm? -114.17 115.97 28.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.118 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 113' ' ' LEU . 79.9 mt -92.92 119.36 32.14 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.994 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -136.47 149.16 48.06 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.4 p -152.26 171.19 18.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.948 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -114.05 118.61 34.56 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.994 0.184 . . . . 0.0 110.558 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 5' ' ' VAL . 4.3 pp -133.87 153.04 52.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.38 0.425 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 mt -122.04 102.29 40.83 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.397 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 155.87 29.48 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.204 1.936 . . . . 0.0 111.392 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.77 -50.61 72.76 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? 179.7 127.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.704 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.6 m 59.49 138.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.604 0.565 . . . . 0.0 110.969 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -89.0 31.37 0.87 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -41.28 94.07 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.427 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -116.88 16.05 15.21 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.093 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mmt -100.54 148.28 24.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -134.64 132.41 38.92 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.712 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.52 132.61 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.016 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -122.57 142.67 50.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -118.99 139.44 51.68 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 95.0 m-85 -126.32 142.59 51.47 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 123.102 0.251 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.7 ptt85 -99.83 80.0 2.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.513 0.673 . . . . 0.0 110.762 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.8 m 56.33 16.67 2.49 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.112 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.02 81.16 58.21 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.306 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.09 -29.91 57.68 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.241 1.96 . . . . 0.0 112.139 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.28 -0.78 57.73 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 63.0 tpp -130.33 88.51 47.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 119.909 -0.091 . . . . 0.0 110.962 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.81 149.77 54.65 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.12 1.88 . . . . 0.0 111.808 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.26 -54.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.953 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.7 tp -152.72 152.25 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.943 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptm -128.21 151.99 48.6 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.088 0.47 . . . . 0.0 112.202 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -120.09 112.34 19.0 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.616 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -135.84 139.29 43.31 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.807 0.337 . . . . 0.0 111.362 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t0 56.64 39.56 29.72 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.395 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.22 12.49 72.37 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.63 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.97 150.46 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.354 0.577 . . . . 0.0 111.655 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -80.58 152.75 28.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.37 139.39 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.341 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.9 m -123.37 129.64 51.58 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.868 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.2 -118.59 2.96 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.27 164.57 59.98 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.265 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.41 -37.12 50.36 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.952 1.768 . . . . 0.0 112.194 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.2 ttp -84.47 112.64 20.56 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -90.07 85.71 6.38 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.037 0.446 . . . . 0.0 110.611 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -41.75 99.81 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.279 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -95.28 -51.92 4.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.822 0.344 . . . . 0.0 111.884 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.16 98.2 Favored Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.113 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 -42.71 99.84 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -72.09 -39.87 68.62 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.94 130.34 56.52 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 120.775 0.322 . . . . 0.0 111.643 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.4 pm0 -134.24 146.04 49.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.836 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -75.05 135.45 41.24 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 27.8 ttt -135.68 103.98 5.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.253 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.73 137.03 58.16 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.82 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 82' ' ' ALA . 99.0 m-20 -61.96 146.74 49.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.111 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.3 m -61.41 -37.55 83.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.203 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 78' ' ' GLU . 90.0 m -60.48 -38.74 85.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 55.03 35.52 24.87 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HB2' HG22 ' A' ' 76' ' ' THR . 10.0 mm-40 -106.2 50.56 0.77 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.377 0.608 . . . . 0.0 110.13 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.63 18.14 76.16 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.978 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.2 m -111.73 143.82 42.02 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.763 0.316 . . . . 0.0 110.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 35.9 m -129.79 158.92 42.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.344 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.537 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . . . -143.24 148.41 36.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 49.2 tp -119.79 123.57 44.01 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.636 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -89.92 119.28 30.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.807 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG23 ' CG2' ' A' ' 88' ' ' VAL . 16.4 tt -118.95 135.0 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.239 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -97.21 147.01 24.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.516 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 55.52 52.78 10.63 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.173 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 20' ' ' ALA . 48.1 t -71.49 139.62 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.441 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.29 172.5 6.6 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -50.55 -37.85 53.36 Favored 'Trans proline' 0 N--CA 1.504 2.097 0 C-N-CA 122.465 2.11 . . . . 0.0 113.44 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 98.4 p -62.06 -32.62 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.728 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.35 -36.71 81.95 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.911 0.386 . . . . 0.0 111.043 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -49.53 128.41 17.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.967 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.51 -148.84 20.05 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.44 145.43 41.16 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.525 ' CD1' HD13 ' A' ' 113' ' ' LEU . 55.8 m-85 -119.33 135.67 54.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.454 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' THR . 37.7 m95 -93.83 133.09 37.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 49.8 t -102.52 114.81 29.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.336 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -112.32 125.41 54.14 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -106.35 117.73 34.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -117.35 130.4 56.49 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -143.55 122.0 12.41 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.442 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.81 -131.58 52.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -100.51 13.38 34.8 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -127.21 132.33 50.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -147.33 161.27 41.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.503 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -128.3 146.53 50.73 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.636 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.22 157.27 47.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' TRP . 8.9 t -146.69 -166.54 2.52 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.411 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.4 p -145.36 147.74 32.62 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 122.629 0.372 . . . . 0.0 110.411 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 96' ' ' TYR . 35.7 m -130.43 153.85 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 4.6 mm? -99.81 117.04 33.28 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 96' ' ' TYR . 4.8 mp -135.77 118.45 16.03 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.476 174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -125.67 111.33 14.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 121.219 -0.193 . . . . 0.0 111.424 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 14' ' ' ALA . 49.9 t -83.44 126.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.054 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.21 139.52 56.05 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.037 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.88 -179.302 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 mmt . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -61.31 -43.69 98.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.52 147.26 49.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 139.68 29.61 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 112.311 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG11 ' SG ' ' A' ' 98' ' ' CYS . 64.7 t -128.65 143.3 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.111 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.87 120.98 60.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.56 ' HA2' HG22 ' A' ' 111' ' ' VAL . . . -101.95 -68.5 0.81 Allowed Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.309 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.08 94.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.868 1.712 . . . . 0.0 110.798 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -137.87 -166.29 1.93 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.511 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.39 128.95 83.41 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.218 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.85 147.29 49.7 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.745 1.63 . . . . 0.0 112.344 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.546 HD12 ' CD2' ' A' ' 113' ' ' LEU . 80.3 mt -117.44 125.73 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 116' ' ' ALA . 4.1 tt -119.31 110.4 16.94 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-O 121.045 0.45 . . . . 0.0 111.6 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.691 ' C ' HG13 ' A' ' 115' ' ' VAL . . . -115.71 -178.1 3.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.483 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.7 140.98 49.82 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 ' HA ' HG13 ' A' ' 88' ' ' VAL . 34.7 m -61.92 143.1 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.285 0.366 . . . . 0.0 110.621 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.38 -24.31 31.0 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 88' ' ' VAL . 59.2 mp0 -99.67 166.58 11.05 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.0 p30 -76.52 158.01 31.6 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -140.0 162.17 35.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.331 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.97 126.28 50.46 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.572 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 113' ' ' LEU . 62.2 mt -107.79 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.8 t -139.45 152.3 46.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.0 p -147.4 166.84 25.95 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.81 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.44 116.47 32.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 120.413 0.149 . . . . 0.0 110.793 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 81' ' ' VAL . 3.4 pp -134.28 151.85 51.49 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.106 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.0 mp -115.18 103.39 54.51 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.024 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.46 142.27 26.32 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.744 1.629 . . . . 0.0 110.945 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.01 -47.53 77.17 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.301 0.572 . . . . 0.0 110.44 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HG2' HG23 ' A' ' 31' ' ' THR . 80.5 ttt180 179.88 126.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' HG2' ' A' ' 30' ' ' ARG . 54.2 p 55.28 157.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.679 0.612 . . . . 0.0 110.907 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -118.33 28.55 8.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.038 0.447 . . . . 0.0 110.649 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.5 -39.6 91.54 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.994 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.07 20.43 17.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.455 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.2 mtt -116.11 147.85 40.9 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -138.28 135.66 35.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.39 129.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.877 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -109.66 137.43 47.49 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -121.54 143.63 49.17 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.921 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.9 156.9 37.21 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.373 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 48' ' ' VAL . 58.5 ttp180 -110.42 78.65 1.14 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m 55.67 15.88 1.74 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.363 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -136.41 92.45 15.42 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.723 0.409 . . . . 0.0 110.442 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.34 -23.18 76.45 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 121.824 1.683 . . . . 0.0 112.198 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -81.15 -30.61 34.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.539 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 45.7 ttm -116.11 104.54 52.12 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.64 156.14 27.89 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.931 1.754 . . . . 0.0 111.482 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 41' ' ' ARG . 35.6 m -103.49 -32.98 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG21 HD21 ' A' ' 83' ' ' LEU . 8.0 tp -160.45 148.07 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.98 152.27 47.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -113.76 113.07 24.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.401 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -136.0 149.77 48.96 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.916 0.389 . . . . 0.0 112.035 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.46 38.14 24.62 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.945 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.8 16.45 70.21 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.998 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.55 146.63 29.51 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 117.123 0.461 . . . . 0.0 111.575 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.49 151.7 25.3 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.853 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.28 156.35 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.747 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -64.21 -35.53 81.12 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.306 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.12 -130.74 49.69 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.59 148.18 90.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.694 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.12 145.84 97.55 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.091 1.861 . . . . 0.0 112.29 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt 61.8 30.99 18.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.878 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -174.83 79.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.997 0.427 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.99 -23.65 39.61 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.571 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -57.2 -17.5 11.58 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 121.202 0.525 . . . . 0.0 109.928 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.84 8.93 61.54 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.79 -0.85 18.48 Favored Glycine 0 CA--C 1.551 2.291 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -117.92 -51.82 2.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.11 148.48 41.76 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -116.08 145.94 42.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.725 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -79.11 127.2 31.72 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.338 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.1 ttt -123.86 102.0 7.56 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.656 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -84.08 136.27 34.08 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.617 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.89 148.32 47.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.949 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.5 m -61.51 -36.27 80.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.031 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.0 m -57.34 -37.3 72.33 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.643 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 61.77 28.74 17.69 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -73.37 3.05 6.41 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.011 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.13 56.62 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.4 m -80.29 138.54 36.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 26' ' ' LEU . 60.1 t -119.03 125.89 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.59 129.92 53.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.09 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 49' ' ' ILE . 54.7 tp -111.34 121.52 45.45 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.724 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -93.37 121.58 34.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.159 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 20' ' ' ALA . 17.4 tt -118.18 136.43 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.52 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -98.42 143.81 28.47 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.548 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 58.25 50.0 10.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.332 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 18' ' ' GLU . 5.6 p -49.54 158.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.01 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 167.07 24.67 Favored Pre-proline 0 N--CA 1.487 1.375 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.345 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.89 -32.77 68.86 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.916 1.744 . . . . 0.0 110.193 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.0 m -62.17 -35.68 79.56 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.575 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 88' ' ' VAL . 36.0 t70 -63.72 -36.86 85.25 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.384 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -56.53 126.67 27.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.153 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.0 -156.12 26.29 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' CG ' HD23 ' A' ' 112' ' ' LEU . 4.1 mp0 -113.53 157.0 22.59 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.486 ' CE2' HD13 ' A' ' 113' ' ' LEU . 16.5 p90 -142.01 149.37 39.92 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.78 34.39 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.558 0.536 . . . . 0.0 111.058 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.471 ' SG ' HG11 ' A' ' 5' ' ' VAL . 50.4 t -85.53 111.81 20.35 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -108.08 138.38 44.44 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.452 ' HE1' HD13 ' A' ' 26' ' ' LEU . 18.0 t80 -112.06 110.79 21.27 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -105.96 119.68 39.81 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.435 0.459 . . . . 0.0 111.395 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -150.27 122.9 8.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.67 -130.65 51.31 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -100.91 13.16 36.01 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -126.7 140.16 52.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.504 0.192 . . . . 0.0 111.482 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.07 160.23 43.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.804 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.6 tpt85 -132.28 137.68 47.58 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.58 138.92 53.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -148.95 140.65 23.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 t -83.96 142.03 30.81 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 113' ' ' LEU . 42.9 t -117.99 143.64 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 95' ' ' GLN . 57.9 mt -95.96 105.64 17.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 22' ' ' LEU . 3.1 mp -134.98 110.19 8.93 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.086 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -119.96 128.88 53.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.647 -0.252 . . . . 0.0 110.594 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 14' ' ' ALA . 60.3 t -100.49 125.47 54.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.977 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -68.28 139.28 55.96 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.127 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.917 -179.252 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -85.26 -177.57 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.913 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.89 143.31 39.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.0 ttp-105 -143.0 150.02 39.07 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.728 0.775 . . . . 0.0 112.399 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.83 141.05 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.591 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.78 118.1 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.004 0.43 . . . . 0.0 109.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 109' ' ' THR . . . -111.24 -31.49 2.83 Favored Glycine 1 CA--C 1.579 4.092 0 CA-C-O 118.703 -1.054 . . . . 0.0 114.543 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 7' ' ' GLY . 75.3 Cg_exo -52.91 -8.29 0.45 Allowed 'Trans proline' 0 N--CA 1.515 2.768 0 CA-C-N 121.002 2.401 . . . . 0.0 114.054 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -35.28 153.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 10' ' ' LEU . 8.1 mp -63.8 154.27 81.39 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.437 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 55.0 Cg_endo -67.27 143.26 63.63 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.016 1.811 . . . . 0.0 112.638 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.16 124.88 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.29 126.21 51.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.997 0.427 . . . . 0.0 111.676 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.83 135.01 39.48 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.009 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 61.9 mtpt -76.95 144.63 38.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.8 p -60.94 135.49 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.028 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.27 -20.62 46.93 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.707 ' O ' HG12 ' A' ' 88' ' ' VAL . 46.9 tt0 -98.92 159.87 14.66 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -75.14 157.28 34.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.699 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 85' ' ' ILE . . . -123.47 162.04 23.65 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.917 HD11 ' HB1' ' A' ' 82' ' ' ALA . 45.9 tp -114.84 121.85 44.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.346 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.37 110.8 22.88 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 151.49 46.18 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.2 p -151.08 163.99 37.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.176 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.82 120.0 41.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.87 152.76 51.8 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.9 tp -120.47 103.47 44.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.42 149.88 45.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.993 1.795 . . . . 0.0 111.899 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.33 -47.35 86.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -160.56 129.15 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.736 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t 41.81 -165.01 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 O-C-N 123.476 0.485 . . . . 0.0 111.505 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.9 t -134.6 28.81 3.6 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.017 0.436 . . . . 0.0 111.305 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.78 87.77 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.349 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -119.72 5.63 11.0 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.31 142.52 32.0 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.581 0.229 . . . . 0.0 111.069 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -128.94 136.54 50.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.806 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.21 128.18 70.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -118.87 139.74 51.12 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.867 0.365 . . . . 0.0 111.947 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -117.18 136.95 52.66 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.056 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' TYR . 96.3 m-85 -124.63 128.81 49.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.485 -177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -84.37 87.12 7.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.1 m 49.39 19.1 0.32 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.86 82.56 17.53 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 122.546 0.338 . . . . 0.0 110.586 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.4 -28.96 87.76 Favored 'Trans proline' 0 N--CA 1.504 2.095 0 C-N-CA 121.918 1.745 . . . . 0.0 112.124 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.28 -33.81 76.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.681 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 43.9 ttm -119.19 110.07 38.26 Favored Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.36 150.45 36.67 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.842 1.695 . . . . 0.0 111.783 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.52 -54.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 83' ' ' LEU . 8.3 tp -148.65 145.22 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.373 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -134.51 153.13 52.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -109.48 115.15 29.4 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.716 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -135.83 146.35 47.41 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.31 0.576 . . . . 0.0 112.418 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 51.59 40.15 26.51 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.987 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.11 13.6 73.07 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.613 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.81 148.79 31.29 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.426 0.613 . . . . 0.0 111.785 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.58 152.3 41.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.663 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.9 p -73.38 120.76 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.0 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.0 m -127.35 130.44 49.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.205 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -126.9 138.49 10.61 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mp 60.53 157.08 0.11 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.343 0.257 . . . . 0.0 110.931 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.85 149.56 77.39 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.188 1.925 . . . . 0.0 111.281 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.6 mtp 66.55 81.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.515 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -50.04 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.51 98.75 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.87 -39.07 16.16 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.614 0.245 . . . . 0.0 111.182 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.36 98.59 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.55 -40.5 98.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -63.72 -41.14 98.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.367 0.127 . . . . 0.0 111.163 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -120.78 119.2 32.03 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -112.75 127.51 56.16 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.619 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -70.22 129.58 39.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.508 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 63.4 tpp -129.8 101.73 6.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.77 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -70.71 134.12 47.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.943 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.8 149.1 51.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -72.12 -12.56 61.25 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.031 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -61.22 -38.19 85.73 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 60.18 38.51 20.11 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.132 0.491 . . . . 0.0 111.361 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -111.75 31.15 6.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.108 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.83 80.83 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.115 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.6 m -80.45 151.44 29.3 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.063 0.459 . . . . 0.0 110.047 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.0 134.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.333 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.917 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.16 139.06 40.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.931 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 49' ' ' ILE . 61.6 tp -121.84 122.22 38.95 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.664 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.61 121.24 32.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.213 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 20' ' ' ALA . 6.8 tp -107.42 134.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -87.89 142.22 27.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 58.02 59.11 3.25 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.643 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 18' ' ' GLU . 6.4 p -61.45 153.4 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.726 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.451 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.88 167.86 12.15 Favored Pre-proline 0 CA--C 1.56 1.353 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.51 -35.5 36.92 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.316 2.011 . . . . 0.0 112.663 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -60.56 -34.93 74.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.149 0.281 . . . . 0.0 110.254 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -64.56 -35.86 82.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.403 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.623 ' HB2' HG22 ' A' ' 115' ' ' VAL . 48.2 t0 -49.7 127.99 17.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.165 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.33 -155.0 25.88 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -114.87 141.1 48.37 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 120.67 0.271 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.654 ' CD1' HD11 ' A' ' 113' ' ' LEU . 39.4 m-85 -116.24 133.11 56.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.547 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -91.73 123.1 34.87 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 48.0 t -95.74 111.19 23.2 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -114.01 119.6 37.76 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.417 0.448 . . . . 0.0 111.124 -176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -94.78 117.33 29.96 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -113.66 124.49 52.43 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 111.519 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -150.14 128.06 11.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.125 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.92 -132.41 52.54 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -103.44 11.95 35.82 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -128.61 133.98 48.45 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.587 0.232 . . . . 0.0 110.588 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 44.7 p90 -147.27 161.47 40.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -138.73 141.3 38.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.737 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -134.94 148.3 50.0 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 7' ' ' GLY . 8.9 t -152.83 148.85 27.67 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.365 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.0 p -82.72 157.5 23.27 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.298 0.571 . . . . 0.0 112.413 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -126.82 137.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.776 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' PRO . 7.5 mp -86.41 118.35 25.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.658 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -136.87 122.87 20.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.403 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.01 142.43 51.18 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.623 HG22 ' HB2' ' A' ' 93' ' ' ASP . 33.6 m -109.11 134.33 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.143 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -69.11 138.21 54.09 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.888 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.872 -179.08 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 tpp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 62.67 -90.62 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.063 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.92 151.35 51.47 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 6' ' ' VAL . 43.6 ttt-85 -137.26 141.93 42.0 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.425 0.631 . . . . 0.0 111.487 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -113.44 130.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.433 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 4' ' ' ARG . 59.0 t -107.2 120.32 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 121.305 0.574 . . . . 0.0 109.747 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 110' ' ' SER . . . -88.87 -43.1 5.5 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.697 -176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.52 113.5 0.87 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 CA-C-N 120.242 2.021 . . . . 0.0 110.997 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.05 172.05 13.98 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.034 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.71 124.32 90.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.061 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 138.54 84.86 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.606 1.537 . . . . 0.0 111.937 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.422 ' HB ' HD22 ' A' ' 113' ' ' LEU . 75.0 mt -112.3 128.93 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 116' ' ' ALA . 2.4 tt -116.04 116.39 27.81 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.266 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.97 134.81 50.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.547 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 tttt -75.8 139.88 42.02 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.31 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 89' ' ' GLN . 8.9 p -50.62 137.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.673 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.66 -21.97 40.29 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 88' ' ' VAL . 80.3 mm-40 -99.78 161.31 13.69 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.8 p30 -75.98 158.37 32.01 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.387 0.429 . . . . 0.0 111.239 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.632 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -136.74 162.87 32.0 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 82' ' ' ALA . 32.7 tp -111.09 122.71 48.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.199 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 113' ' ' LEU . 32.0 mt -107.17 113.25 26.56 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -140.58 147.67 39.79 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.97 170.82 15.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.135 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -108.15 116.51 32.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.223 0.535 . . . . 0.0 111.381 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 HG21 ' A' ' 81' ' ' VAL . 3.9 pp -134.05 166.29 23.09 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.949 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.61 158.78 56.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.062 -174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -12.48 129.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 125.3 4.0 . . . . 0.0 116.496 -170.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -86.56 -9.84 55.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.031 -1.44 . . . . 0.0 111.488 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -92.1 140.45 29.62 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 m 75.7 27.72 0.97 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.42 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.6 p -91.23 39.13 0.99 Allowed 'General case' 0 C--O 1.25 1.121 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.67 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.84 94.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -109.66 13.19 23.91 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -104.2 150.93 23.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 120.742 0.306 . . . . 0.0 111.064 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -130.59 145.1 51.82 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.244 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.05 129.92 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -124.68 144.71 50.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.1 139.31 53.5 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.035 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.68 125.51 36.18 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -80.68 79.27 7.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.296 0.569 . . . . 0.0 110.376 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 p 50.26 21.45 0.8 Allowed 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.066 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -136.17 88.48 21.52 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.192 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.96 -21.28 68.65 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.17 1.913 . . . . 0.0 113.088 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.45 -2.05 57.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.1 tpp -132.99 84.39 49.13 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.27 139.08 88.41 Favored 'Trans proline' 0 N--CA 1.507 2.298 0 C-N-CA 122.01 1.807 . . . . 0.0 111.423 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.25 -38.66 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 tp -167.17 154.89 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -142.44 152.33 42.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -107.94 107.59 18.36 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -123.83 136.01 54.12 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.911 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.6 t0 53.2 45.68 28.09 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.172 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 11.86 67.36 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.658 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.07 29.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.429 0.615 . . . . 0.0 111.847 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -71.93 144.4 48.96 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.236 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.1 p -56.66 115.89 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.88 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -69.99 -37.36 75.71 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.43 -132.92 43.0 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 60' ' ' LEU . 3.6 mm? -74.93 156.82 86.09 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.673 -0.264 . . . . 0.0 110.594 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.27 -23.66 75.46 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.014 1.809 . . . . 0.0 112.284 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.8 mtt -62.57 -39.68 94.45 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 55.77 52.83 10.24 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.364 0.602 . . . . 0.0 110.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.33 -41.74 99.59 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -94.07 -46.53 7.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.545 0.212 . . . . 0.0 111.463 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.83 99.69 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.98 -41.68 99.68 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.2 ttp-105 -64.6 -41.22 96.37 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.596 -0.302 . . . . 0.0 111.649 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.02 56.05 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -126.26 141.82 51.77 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.809 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -76.56 125.88 30.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 60.6 ttm -136.1 101.57 4.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.058 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.98 140.11 58.83 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -77.81 174.96 10.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.151 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -83.98 -11.58 56.6 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.407 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 78' ' ' GLU . 90.0 m -63.95 -38.42 91.03 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 59.98 22.1 11.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.441 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 76' ' ' THR . 17.0 pt-20 -73.65 0.95 11.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.46 7.94 55.29 Favored Glycine 0 CA--C 1.548 2.1 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.0 p -82.45 160.9 22.6 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-O 120.677 0.275 . . . . 0.0 110.634 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.579 HG21 HD21 ' A' ' 26' ' ' LEU . 58.0 t -123.77 125.1 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -113.12 131.75 55.71 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.57 0.544 . . . . 0.0 110.832 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -113.84 121.63 44.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.569 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -89.12 119.59 29.76 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.28 133.68 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.312 0.383 . . . . 0.0 110.488 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -100.38 154.29 18.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.861 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 58.55 58.96 3.12 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.828 0.823 . . . . 0.0 111.411 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 115' ' ' VAL . 59.9 t -66.49 151.1 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.47 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.549 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -145.71 168.6 11.47 Favored Pre-proline 0 CA--C 1.564 1.516 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.37 -36.62 48.52 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.465 2.11 . . . . 0.0 113.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.2 p -61.31 -32.33 72.18 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.668 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -65.26 -36.07 82.98 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 120.802 0.334 . . . . 0.0 110.115 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -51.29 131.76 28.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 129.39 -153.62 19.98 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -113.65 150.95 32.44 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.566 0.222 . . . . 0.0 110.753 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.402 ' HD2' HD12 ' A' ' 113' ' ' LEU . 1.6 p90 -123.28 142.09 51.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.817 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -91.21 119.87 31.66 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.413 0.446 . . . . 0.0 110.164 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 44.7 t -85.56 116.01 23.6 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -107.98 132.12 53.84 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -117.09 112.43 20.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -116.16 128.43 55.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.1 129.7 20.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.947 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.57 -131.48 51.07 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -101.23 11.74 38.8 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -129.04 137.95 51.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.462 0.172 . . . . 0.0 110.93 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -143.21 158.2 43.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.198 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -134.84 148.23 50.1 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.267 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.98 158.34 36.4 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.5 m -150.76 148.37 28.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.928 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 7' ' ' GLY . 84.2 p -80.67 155.73 26.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -176.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.7 t -125.99 147.82 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.565 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 113' ' ' LEU . 86.2 mt -91.81 106.25 18.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.312 0.382 . . . . 0.0 111.794 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 22' ' ' LEU . 42.1 mt -134.28 101.31 4.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.413 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -108.68 129.22 55.35 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 88' ' ' VAL . 35.0 m -106.14 139.61 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 123.39 0.431 . . . . 0.0 111.205 -177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.682 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.47 143.37 53.55 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.912 -179.494 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 p30 -84.96 -179.19 7.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.803 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.23 143.47 50.93 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.123 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -140.42 146.42 38.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.481 0.658 . . . . 0.0 111.595 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 98' ' ' CYS . 70.3 t -112.42 130.47 66.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.699 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.1 119.21 46.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.94 -47.94 2.17 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.332 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.24 114.66 1.38 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 CA-C-N 119.79 1.795 . . . . 0.0 111.083 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -147.61 169.42 19.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.083 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.9 mt -71.47 130.67 87.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -54.79 138.07 76.0 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.704 1.603 . . . . 0.0 111.593 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.19 122.84 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.947 0.403 . . . . 0.0 110.096 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.91 120.12 38.82 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.649 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.96 122.6 23.31 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.833 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 38.1 ttpt -71.99 138.51 48.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 89' ' ' GLN . 54.6 t -58.28 133.02 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.515 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.81 -30.97 8.67 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.2 mt-10 -99.46 164.71 11.98 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -77.05 157.99 30.79 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.736 0.303 . . . . 0.0 111.656 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -121.14 164.04 17.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.775 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.5 tp -126.02 121.14 32.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 -178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.98 131.17 54.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.437 ' O ' HG11 ' A' ' 111' ' ' VAL . 10.2 t -146.3 162.07 38.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.9 p -146.81 159.8 43.06 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.685 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -109.67 118.47 36.64 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.346 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 81' ' ' VAL . 4.3 pp -133.52 152.96 51.98 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.8 tt -113.69 104.66 55.2 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.69 146.99 21.62 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.978 1.785 . . . . 0.0 111.686 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.32 -46.87 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -173.04 128.8 0.47 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.819 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.64 -171.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.309 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -135.0 30.38 3.35 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.875 0.369 . . . . 0.0 111.441 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.42 96.46 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.251 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -112.46 15.81 20.06 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.968 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -101.95 148.87 24.83 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -127.8 133.35 49.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.024 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.07 128.8 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -125.68 144.91 50.4 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.07 0.462 . . . . 0.0 112.151 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -124.56 147.22 48.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.406 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.96 136.98 52.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.841 0.353 . . . . 0.0 111.731 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' NH2' HD11 ' A' ' 85' ' ' ILE . 41.7 ttm180 -89.14 79.74 7.11 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.45 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.5 m 52.02 18.47 0.83 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.444 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -133.34 85.17 44.75 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 122.655 0.382 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.24 -26.05 80.42 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.042 1.828 . . . . 0.0 112.753 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -91.71 2.11 56.7 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.0 tpt -134.68 90.62 22.78 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-O 119.523 -0.275 . . . . 0.0 111.081 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.33 138.3 38.84 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 C-N-CA 121.799 1.666 . . . . 0.0 111.761 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.37 -45.19 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.573 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CG2' HD21 ' A' ' 83' ' ' LEU . 9.6 tp -157.27 151.71 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -141.03 152.96 45.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.31 115.53 30.28 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.612 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.6 ttp-105 -133.62 135.36 44.16 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.877 0.37 . . . . 0.0 111.462 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.85 39.19 30.69 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.647 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.37 17.31 72.29 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.228 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.77 146.78 30.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.993 0.397 . . . . 0.0 111.291 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.48 152.22 45.63 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.11 122.91 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.449 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m 50.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.692 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -46.15 94.43 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp 57.14 137.56 0.03 OUTLIER Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.61 -37.06 73.85 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.719 1.613 . . . . 0.0 110.808 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -136.72 71.11 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 110.802 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pm0 -43.86 109.87 0.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.017 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.58 -41.62 96.01 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.026 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.79 -38.56 11.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.708 0.289 . . . . 0.0 110.758 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.21 95.15 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.6 97.86 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.43 -41.66 93.29 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.78 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -121.61 112.99 19.14 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.606 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.83 130.28 55.4 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -64.58 126.61 28.42 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.651 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 28.0 ttt -136.71 130.13 31.6 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.811 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -100.93 139.72 36.22 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 123.291 0.369 . . . . 0.0 110.247 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -73.08 166.8 22.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 t -63.74 -38.66 91.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.843 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 78' ' ' GLU . 44.0 m -60.1 -39.12 85.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.735 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 50.66 36.93 15.16 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 76' ' ' THR . 14.4 pt-20 -88.09 35.24 0.74 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.86 6.48 82.48 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.854 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 t -81.99 138.45 34.91 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.035 0.418 . . . . 0.0 110.527 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 26' ' ' LEU . 60.5 t -114.03 124.8 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -120.73 143.21 48.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.914 0.388 . . . . 0.0 111.516 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -121.16 123.8 43.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.939 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -90.55 120.36 31.58 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.638 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.473 HD11 ' NH2' ' A' ' 41' ' ' ARG . 17.9 tt -113.57 128.95 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 123.266 0.354 . . . . 0.0 110.597 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -89.35 150.6 22.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 57.3 68.61 0.83 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.488 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 20' ' ' ALA . 97.4 t -67.37 146.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.489 ' HA ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -150.19 172.04 5.71 Favored Pre-proline 0 CA--C 1.572 1.797 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.743 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.33 -32.55 42.19 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 C-N-CA 122.204 1.936 . . . . 0.0 112.117 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -60.3 -36.3 77.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.609 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 93.8 m-20 -64.17 -36.03 82.71 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.07 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 115' ' ' VAL . 47.2 t0 -51.09 119.44 3.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.68 -151.24 23.29 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.574 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.645 HE22 HD23 ' A' ' 112' ' ' LEU . 18.6 mm100 -113.47 146.16 40.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.403 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 m-85 -125.35 135.67 52.67 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -94.79 135.18 36.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.813 0.339 . . . . 0.0 111.706 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.416 ' O ' HG11 ' A' ' 5' ' ' VAL . 54.1 t -106.13 118.16 35.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -113.8 121.64 44.65 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.124 0.265 . . . . 0.0 111.038 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -105.86 117.9 35.22 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -119.85 125.87 49.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.192 0.52 . . . . 0.0 111.675 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -143.12 130.34 20.86 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.38 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.22 -129.15 47.28 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -109.37 17.57 21.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.26 131.97 47.11 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -147.47 161.51 40.92 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.974 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.29 145.11 25.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -140.46 154.86 46.78 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.3 m -147.91 148.22 30.58 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.056 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.7 p -80.87 161.36 24.44 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 96' ' ' TYR . 31.7 m -124.89 152.46 31.21 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.916 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.645 HD23 HE22 ' A' ' 95' ' ' GLN . 64.3 mt -89.5 111.44 22.34 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.672 0.608 . . . . 0.0 110.75 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 96' ' ' TYR . 34.9 mt -133.65 122.22 23.13 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.306 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -126.15 142.72 51.41 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG11 ' CG1' ' A' ' 88' ' ' VAL . 33.4 m -117.28 137.23 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 110.866 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . . . -69.67 141.95 53.49 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.593 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.835 -179.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 t0 67.69 -70.15 0.13 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.32 139.51 40.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.5 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.42 149.87 44.58 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.571 0.7 . . . . 0.0 111.871 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 98' ' ' CYS . 57.9 t -117.98 138.26 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.144 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG12 ' HD3' ' A' ' 8' ' ' PRO . 49.0 t -127.24 131.35 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.593 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.37 68.07 0.22 Allowed Glycine 0 CA--C 1.55 2.279 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD3' HG12 ' A' ' 6' ' ' VAL . 65.0 Cg_endo -81.64 -8.5 12.43 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 122.213 1.942 . . . . 0.0 112.308 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -61.68 135.3 57.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.391 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD12 ' C ' ' A' ' 10' ' ' LEU . 4.6 pp -74.57 158.86 84.53 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.128 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' O ' HD12 ' A' ' 10' ' ' LEU . 9.3 Cg_endo -51.4 129.28 28.6 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.515 1.477 . . . . 0.0 111.184 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.1 mt -99.24 128.75 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.975 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mp -97.51 124.45 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.18 134.24 30.89 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.263 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 38.4 mtmm -81.02 147.04 30.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.59 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 89' ' ' GLN . 9.7 p -58.17 133.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.03 -22.09 40.33 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.59 162.74 12.84 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -76.77 158.05 31.18 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 123.398 0.436 . . . . 0.0 111.602 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -126.81 163.23 24.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.391 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 82' ' ' ALA . 38.0 tp -123.56 122.18 37.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.772 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -117.22 118.5 32.46 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.1 t -135.88 146.59 47.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.6 p -138.45 163.22 32.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.19 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -114.26 119.7 37.9 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.369 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 HD12 ' HD3' ' A' ' 28' ' ' PRO . 3.4 pp -132.96 152.08 51.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.29 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.4 101.12 44.5 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' HD12 ' A' ' 26' ' ' LEU . 79.8 Cg_endo -80.89 147.12 16.74 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.158 1.906 . . . . 0.0 111.4 177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -63.92 -42.06 97.48 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.827 0.346 . . . . 0.0 110.266 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -171.18 128.25 0.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.6 p 47.2 -173.03 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.275 0.36 . . . . 0.0 111.218 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -134.64 42.1 2.85 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.482 0.658 . . . . 0.0 110.31 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.05 92.58 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.08 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 1.32 10.4 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.93 148.04 28.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.391 0.138 . . . . 0.0 111.115 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -128.11 141.47 51.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.089 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.7 t -124.65 130.1 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.84 139.29 50.34 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.018 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -119.17 133.96 55.48 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.63 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -127.26 125.69 41.36 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.568 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.9 87.67 5.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.39 0.614 . . . . 0.0 111.239 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.8 m 54.01 17.25 1.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.374 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -133.27 70.87 77.31 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 122.393 0.277 . . . . 0.0 110.413 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.23 -35.9 75.61 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.141 1.894 . . . . 0.0 112.201 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.45 -26.75 68.09 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.9 ttt -129.54 115.07 18.22 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.69 151.95 37.08 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.824 1.683 . . . . 0.0 111.584 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -102.99 -29.78 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.44 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' CG2' HD21 ' A' ' 83' ' ' LEU . 8.3 tp -161.31 155.23 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.715 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.2 ptp -139.36 152.08 46.86 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.899 0.38 . . . . 0.0 111.467 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -119.91 114.44 22.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -137.94 149.5 46.22 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 51.99 38.92 25.09 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.853 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.74 15.44 73.58 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.268 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.41 146.81 29.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.331 0.566 . . . . 0.0 111.656 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -82.15 152.6 26.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.915 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.82 139.8 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.493 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 t -148.41 153.53 38.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.494 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.35 179.46 48.59 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.6 mt 58.6 164.06 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 119.613 -0.232 . . . . 0.0 110.809 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.9 -37.49 85.55 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.114 1.876 . . . . 0.0 111.322 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 28.0 ttt -125.42 129.35 49.69 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.928 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.92 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.29 -41.06 99.74 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -93.71 -36.89 12.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.643 0.259 . . . . 0.0 111.084 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.95 -39.28 96.78 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.86 98.55 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -70.71 -43.45 68.96 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.317 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -124.93 131.18 53.46 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.216 0.322 . . . . 0.0 111.099 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -139.45 151.34 46.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.284 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -89.68 124.59 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.843 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.621 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 66.1 ttp -135.9 126.64 27.32 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.295 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -71.29 140.62 50.39 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.531 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -79.06 177.15 9.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.43 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.2 t -64.7 -38.95 92.75 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.5 m -61.09 -39.23 89.12 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 -176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 47.93 28.07 1.32 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.564 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -112.46 72.24 0.77 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.338 0.589 . . . . 0.0 110.808 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.24 23.4 74.81 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.455 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 t -113.05 140.09 48.14 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.85 148.98 26.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.944 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -134.44 143.41 47.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD21 ' CG2' ' A' ' 49' ' ' ILE . 45.1 tp -117.15 119.03 33.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -89.94 114.95 26.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -111.47 134.45 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.817 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -107.89 156.22 19.42 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.913 0.387 . . . . 0.0 111.847 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 62.18 59.45 1.62 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.012 0.91 . . . . 0.0 110.881 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 20' ' ' ALA . 60.3 t -71.1 145.11 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.787 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.44 ' HA ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -147.17 168.55 11.1 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.349 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.03 -38.4 49.36 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 122.5 2.133 . . . . 0.0 113.416 -175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.7 p -61.34 -30.95 70.83 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.448 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 55.8 t0 -65.69 -35.87 82.01 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.989 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -48.55 127.93 14.13 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.771 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.63 -156.14 26.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -113.87 156.37 24.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.684 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -125.18 142.34 51.56 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.224 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -94.96 119.29 33.24 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.475 0.485 . . . . 0.0 110.667 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.42 ' HB3' HG11 ' A' ' 5' ' ' VAL . 41.3 t -87.76 110.74 20.69 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -104.97 124.68 49.93 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.33 0.394 . . . . 0.0 111.363 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -102.96 118.71 37.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.07 123.26 49.38 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -143.5 126.86 16.72 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.301 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.86 -130.75 51.48 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 7.39 39.68 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -128.24 138.7 52.56 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.578 0.228 . . . . 0.0 110.673 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -146.86 161.17 41.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -147.49 147.79 30.54 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -137.55 149.52 46.78 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 m -136.43 142.89 43.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.809 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.7 p -80.75 159.36 25.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.419 0.628 . . . . 0.0 112.644 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.7 t -135.25 151.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.9 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.7 mt -89.94 126.54 35.77 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 22' ' ' LEU . 36.2 mt -132.81 123.66 26.54 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -127.82 101.13 6.21 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.655 0.264 . . . . 0.0 110.315 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG11 ' CG1' ' A' ' 88' ' ' VAL . 26.1 m -82.91 134.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.775 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . . . -70.99 143.68 50.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.393 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.851 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttp . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -61.12 -39.88 91.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.991 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -132.46 150.76 52.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.87 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -146.5 145.88 30.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 25' ' ' GLN . 9.4 p -129.73 150.89 35.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.0 t -105.89 123.13 60.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.24 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.27 -47.02 2.47 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.059 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.1 101.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 119.704 1.752 . . . . 0.0 111.262 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -143.3 165.04 28.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -69.84 151.57 96.27 Favored Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 123.45 0.469 . . . . 0.0 111.502 179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.18 141.28 95.68 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.99 1.793 . . . . 0.0 112.146 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 113' ' ' LEU . 72.9 mt -105.17 119.76 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.7 tt -103.52 123.09 46.28 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.84 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HD23 ' A' ' 13' ' ' LEU . . . -140.92 138.27 33.73 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.367 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 69.0 mttm -84.16 147.15 27.48 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.98 135.86 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.069 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.19 -21.6 43.21 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 88' ' ' VAL . 53.0 mt-10 -98.9 161.5 13.6 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -76.04 157.55 32.86 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.46 160.41 32.38 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.768 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.603 HD11 ' HB1' ' A' ' 82' ' ' ALA . 28.4 tp -114.1 124.72 52.8 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.946 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.89 118.53 36.36 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 HD11 ' A' ' 12' ' ' ILE . 10.1 t -140.63 147.7 39.74 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.1 p -148.41 166.95 26.58 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 5' ' ' VAL . 72.5 mt-30 -114.56 118.58 34.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.591 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.32 153.3 50.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.38 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.97 104.06 55.65 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.487 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.76 135.94 22.39 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.728 1.619 . . . . 0.0 111.674 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.67 -44.28 78.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.418 0.628 . . . . 0.0 109.937 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -145.19 -177.91 5.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.972 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.6 m -48.12 139.99 7.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -81.56 28.91 0.38 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.61 66.99 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -119.56 -9.28 9.84 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -82.08 150.79 27.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.844 0.458 . . . . 0.0 111.019 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -141.19 142.83 33.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.708 178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 ' CH2' ' A' ' 39' ' ' TRP . 27.2 m -131.18 150.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.003 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -129.26 144.69 51.32 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.505 ' CH2' HG23 ' A' ' 37' ' ' VAL . 32.2 m-90 -119.61 138.18 53.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.58 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.57 127.55 39.27 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -86.81 79.24 8.88 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.4 m 51.77 26.5 3.54 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.0 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -139.68 72.85 35.58 Favored Pre-proline 0 CA--C 1.562 1.42 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.71 -35.45 68.7 Favored 'Trans proline' 0 N--CA 1.506 2.218 0 C-N-CA 122.28 1.987 . . . . 0.0 112.328 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -64.83 -33.18 75.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.94 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 18.2 tpt -121.97 100.28 43.19 Favored Pre-proline 0 CA--C 1.564 1.512 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.664 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.99 140.12 34.19 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.944 1.762 . . . . 0.0 111.522 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.4 t -67.69 -48.18 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 57' ' ' VAL . 7.8 tp -167.5 160.25 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.316 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -140.45 151.96 45.28 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 112.185 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -100.93 106.95 18.33 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.2 133.23 53.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.289 0.566 . . . . 0.0 111.983 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 55.29 41.33 31.37 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.567 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.56 14.91 75.16 Favored Glycine 0 CA--C 1.541 1.712 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.151 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.15 142.69 28.71 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 116.945 0.372 . . . . 0.0 110.901 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.32 152.36 24.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.61 ' O ' HD11 ' A' ' 49' ' ' ILE . 86.7 t -72.73 122.3 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.635 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -135.87 160.83 37.37 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.807 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.84 130.48 10.22 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 60' ' ' LEU . 8.5 mp -62.52 -48.08 87.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.48 -41.3 73.4 Favored 'Trans proline' 0 N--CA 1.511 2.506 0 C-N-CA 121.855 1.703 . . . . 0.0 112.554 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 80.0 mtm -141.56 146.95 36.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -90.4 24.0 2.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.22 98.45 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.86 -52.7 13.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.95 95.44 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.48 99.42 Favored Glycine 0 N--CA 1.463 0.474 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.3 ttm105 -60.39 -47.56 85.54 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.357 -0.137 . . . . 0.0 110.846 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.74 115.97 26.09 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.716 0.293 . . . . 0.0 110.994 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -115.38 119.79 37.43 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.943 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -71.48 124.8 25.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.8 ttp -132.51 128.74 37.98 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.99 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.21 139.77 56.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.75 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.15 154.94 21.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.046 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.4 t -59.77 -38.85 82.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.83 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.0 m -63.29 -37.86 88.9 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.27 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.01 34.88 8.74 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -101.15 54.28 0.84 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.601 0.715 . . . . 0.0 109.692 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.32 1.02 89.87 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.824 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -81.73 143.7 31.65 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 117.033 0.417 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.18 149.91 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.23 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -147.85 148.6 31.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.374 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 49' ' ' ILE . 52.0 tp -123.5 124.47 42.93 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.104 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -89.74 116.92 28.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.0 tp -108.96 135.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.918 0.39 . . . . 0.0 110.734 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -87.64 138.8 31.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.285 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 58.3 56.68 4.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.743 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 18' ' ' GLU . 8.8 p -53.94 153.52 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.15 168.24 11.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.37 -34.96 42.93 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.481 2.12 . . . . 0.0 112.893 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -60.38 -35.04 74.79 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -65.78 -35.72 81.52 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -48.82 128.02 14.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.668 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.45 -154.79 25.73 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -113.81 147.83 37.67 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.454 0.169 . . . . 0.0 110.74 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.24 144.05 49.21 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -99.37 119.98 38.84 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.526 0.516 . . . . 0.0 110.396 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.02 111.53 20.38 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -117.26 118.73 33.1 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 120.652 0.263 . . . . 0.0 111.651 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -97.01 123.37 40.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.234 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -116.99 121.91 42.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.62 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -149.5 132.14 15.87 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.218 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.21 -130.33 50.55 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -106.38 12.58 29.62 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -127.87 143.75 51.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.612 0.244 . . . . 0.0 111.578 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -148.01 158.62 44.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.497 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.63 146.67 33.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.247 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -148.51 148.22 29.98 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.7 m -143.4 144.5 32.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.698 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.6 p -80.5 154.52 27.52 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 0.0 112.136 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.7 151.41 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 113' ' ' LEU . 1.2 mm? -95.61 114.0 25.71 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.891 0.377 . . . . 0.0 111.875 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -128.65 117.47 21.25 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.126 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.21 142.65 49.71 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -119.42 135.53 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.735 0.302 . . . . 0.0 111.249 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -70.99 143.57 50.78 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.63 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.856 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.76 -41.59 97.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.183 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -134.45 147.51 50.42 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.545 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.543 ' NH1' HG22 ' A' ' 6' ' ' VAL . 32.8 ttt-85 -146.43 149.42 33.67 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 109' ' ' THR . 56.2 t -121.73 132.74 70.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG12 ' HD3' ' A' ' 8' ' ' PRO . 47.2 t -127.09 132.78 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.112 0.258 . . . . 0.0 110.427 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.1 70.64 0.27 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 111.611 -0.595 . . . . 0.0 111.611 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' HG12 ' A' ' 6' ' ' VAL . 28.0 Cg_endo -92.16 1.06 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.604 2.203 . . . . 0.0 111.976 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -59.56 141.53 54.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 111.804 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 87.9 mt -70.9 157.59 89.97 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.616 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' HD13 ' A' ' 112' ' ' LEU . 21.2 Cg_endo -59.16 137.39 78.87 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.531 1.487 . . . . 0.0 111.583 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 113' ' ' LEU . 79.8 mt -103.78 122.91 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 116' ' ' ALA . 1.4 tt -106.07 117.62 34.51 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.883 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.75 137.7 45.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.411 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 59.5 mtmt -72.83 145.76 46.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.14 139.11 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.992 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.54 -21.88 43.24 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HG12 ' A' ' 88' ' ' VAL . 1.3 mp0 -99.38 167.02 10.9 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -76.39 157.16 32.59 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.952 0.406 . . . . 0.0 111.24 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.16 162.82 25.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.376 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HB1' ' A' ' 82' ' ' ALA . 4.5 tt -124.27 123.04 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 113' ' ' LEU . 9.1 mt -104.98 116.88 32.7 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -139.26 147.12 41.27 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.9 p -148.83 164.98 32.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.691 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -112.81 121.02 43.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.99 0.424 . . . . 0.0 111.872 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 81' ' ' VAL . 4.2 pp -133.26 153.53 51.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.306 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.09 104.0 50.27 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.561 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.01 146.08 20.05 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.096 1.864 . . . . 0.0 111.931 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.7 -25.06 23.65 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.451 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -168.05 -174.84 2.47 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.9 p -48.12 151.52 0.98 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.8 p -88.63 36.31 0.79 Allowed 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.183 0.516 . . . . 0.0 111.885 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.09 93.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.496 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -114.26 32.16 6.1 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -126.29 149.54 49.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -131.74 135.59 46.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.136 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.55 128.96 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -118.68 140.11 50.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -119.65 147.81 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.061 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 85.6 m-85 -131.01 154.49 48.13 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 120.839 0.352 . . . . 0.0 111.746 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HE ' HG21 ' A' ' 48' ' ' VAL . 79.9 mtm180 -117.21 78.56 1.23 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p 61.82 7.24 1.91 Allowed 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.201 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.74 73.97 80.56 Favored Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 122.319 0.248 . . . . 0.0 110.571 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.1 -35.68 73.65 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 122.378 2.052 . . . . 0.0 112.108 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.24 -34.19 76.04 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.521 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 41.7 ttm -114.33 110.44 47.85 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.761 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.89 150.55 38.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.78 1.653 . . . . 0.0 111.778 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 HG21 ' HE ' ' A' ' 41' ' ' ARG . 57.1 t -97.98 -54.31 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.328 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.6 tp -145.66 146.7 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -136.0 151.9 50.38 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.023 0.44 . . . . 0.0 111.483 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -113.62 108.55 17.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.279 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -129.14 140.74 51.42 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.084 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.12 39.57 30.34 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.955 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 19.26 71.26 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.227 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.69 149.77 33.09 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.245 0.523 . . . . 0.0 112.066 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.2 152.85 26.24 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.748 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.28 156.68 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.717 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p 50.43 76.72 0.14 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.776 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.81 -19.43 1.82 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.774 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -59.28 -48.71 95.59 Favored Pre-proline 0 CA--C 1.564 1.488 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.896 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.55 76.22 1.9 Allowed 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.78 1.653 . . . . 0.0 112.807 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm 56.24 27.35 11.6 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.58 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.48 44.5 9.79 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.77 -44.14 98.33 Favored Glycine 0 N--CA 1.465 0.586 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.09 -44.54 7.61 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.535 0.207 . . . . 0.0 111.119 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.32 99.73 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.4 98.69 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.96 -44.6 97.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.77 -0.215 . . . . 0.0 111.026 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 83' ' ' LEU . . . -115.02 116.85 29.12 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-O 120.765 0.317 . . . . 0.0 111.271 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -118.33 135.15 54.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.958 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -73.95 130.44 39.87 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 123.259 0.35 . . . . 0.0 111.256 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 15.7 tpt -134.17 98.91 4.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.337 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.63 140.77 49.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.541 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -79.62 179.03 7.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.1 m -84.38 -10.68 57.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 78' ' ' GLU . 86.3 m -63.83 -38.84 92.59 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.28 36.02 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HB2' HG22 ' A' ' 76' ' ' THR . 13.4 mm-40 -110.18 30.52 6.67 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.014 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.67 75.21 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.287 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.0 t -80.89 136.44 36.06 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 26' ' ' LEU . 55.7 t -119.0 126.97 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.352 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 72' ' ' MET . . . -123.99 133.12 53.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.116 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 69' ' ' ALA . 57.2 tp -115.26 124.15 50.62 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.978 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -92.81 121.69 34.44 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -116.99 135.86 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.658 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -97.97 150.24 21.57 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.03 56.96 5.45 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.314 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -57.02 157.95 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.843 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -150.71 168.68 10.55 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.9 -37.61 56.25 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.385 2.056 . . . . 0.0 112.852 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.9 p -61.23 -31.54 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.471 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 88' ' ' VAL . 46.2 t0 -64.79 -36.23 83.64 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.912 0.387 . . . . 0.0 109.993 175.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 115' ' ' VAL . 13.5 t70 -49.48 127.02 14.55 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.52 -153.15 25.1 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -113.87 149.51 34.98 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.208 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.484 ' HD2' HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -123.94 129.32 50.78 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.329 174.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' THR . 34.6 m0 -87.64 119.97 28.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 5' ' ' VAL . 51.5 t -85.5 118.21 24.89 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.099 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -114.25 130.65 56.64 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.823 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -113.61 116.89 30.21 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -113.03 126.58 55.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.228 0.537 . . . . 0.0 111.871 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.0 123.94 17.55 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.533 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.4 -130.35 50.23 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -101.89 10.92 39.38 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -125.82 137.03 53.75 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.601 0.239 . . . . 0.0 110.775 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -145.02 158.85 43.68 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.156 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -127.07 143.14 51.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.847 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -129.9 154.76 46.99 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 5' ' ' VAL . 12.7 t -143.52 -159.61 1.0 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.497 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.3 p -147.28 150.86 35.63 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.74 145.06 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.783 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.405 HD13 ' HD3' ' A' ' 11' ' ' PRO . 67.4 mt -85.6 116.84 24.13 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.241 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 22' ' ' LEU . 54.5 mt -134.08 127.58 32.47 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -128.78 144.52 51.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.084 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 88' ' ' VAL . 33.7 m -120.75 132.12 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.815 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.654 ' HB2' HD21 ' A' ' 13' ' ' LEU . . . -69.7 143.11 53.22 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.819 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.62 143.67 2.78 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.76 149.3 52.29 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.223 0.327 . . . . 0.0 110.268 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.56 160.97 42.04 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.565 ' O ' HG21 ' A' ' 109' ' ' THR . 40.9 t -109.92 148.63 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.27 118.02 47.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.55 -49.55 1.81 Allowed Glycine 0 CA--C 1.535 1.298 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.96 109.09 0.29 Allowed 'Trans proline' 0 C--N 1.363 1.316 0 CA-C-N 119.339 1.57 . . . . 0.0 110.57 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' OD1' HG13 ' A' ' 111' ' ' VAL . 19.7 p30 -161.41 -179.14 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.7 146.48 72.89 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.441 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 149.47 38.8 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.985 1.79 . . . . 0.0 111.537 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.0 mt -113.79 125.04 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.201 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.38 122.34 46.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.024 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.34 140.04 37.42 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.562 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.59 152.95 22.17 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.03 138.89 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.656 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.71 38.44 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.654 ' O ' HG12 ' A' ' 88' ' ' VAL . 79.8 mm-40 -99.28 161.98 13.31 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 p30 -76.76 157.53 31.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.855 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.5 162.27 23.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.084 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.824 ' O ' HD21 ' A' ' 113' ' ' LEU . 24.9 tp -127.58 112.86 15.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.165 0.29 . . . . 0.0 111.582 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.1 HD23 HD22 ' A' ' 113' ' ' LEU . 2.6 mt -100.24 125.2 46.39 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -145.89 151.72 38.31 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.66 162.36 35.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.65 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.16 116.44 31.54 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 26' ' ' LEU . 4.1 pp -132.63 153.24 51.26 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 tp -114.55 103.12 55.08 Favored Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.671 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.42 154.73 24.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.256 1.971 . . . . 0.0 111.579 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -62.97 -42.3 99.79 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.013 0.435 . . . . 0.0 110.015 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -174.99 129.61 0.3 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.22 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t 42.62 -163.75 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 O-C-N 123.42 0.45 . . . . 0.0 111.172 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 t -133.69 30.31 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.91 0.386 . . . . 0.0 111.52 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.34 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -115.3 19.01 15.85 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.77 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.54 151.23 23.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.882 0.372 . . . . 0.0 111.267 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -135.86 125.87 26.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.32 128.03 75.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -118.2 127.89 54.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.515 ' CD1' ' CE1' ' A' ' 96' ' ' TYR . 13.4 m-90 -113.09 135.97 53.21 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.7 125.17 50.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -80.58 86.55 5.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.988 0.423 . . . . 0.0 110.309 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m 50.56 16.69 0.31 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.058 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -135.14 80.61 46.97 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 122.643 0.377 . . . . 0.0 110.299 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.07 -30.4 90.12 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.582 1.522 . . . . 0.0 111.431 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.06 -32.89 69.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.635 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.4 tpt -115.92 103.48 53.45 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.56 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 148.96 58.26 Favored 'Trans proline' 0 N--CA 1.513 2.622 0 C-N-CA 122.321 2.014 . . . . 0.0 111.809 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.25 -43.28 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.498 HG21 HD21 ' A' ' 83' ' ' LEU . 6.1 tp -158.09 144.85 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.317 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.0 ptp -133.73 152.64 51.93 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -113.16 115.38 28.17 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.698 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -135.3 140.28 45.01 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.915 0.388 . . . . 0.0 111.922 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 t0 55.55 40.95 31.18 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.637 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.83 13.87 69.65 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.19 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.69 146.12 30.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 117.062 0.431 . . . . 0.0 111.226 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.5 pm0 -88.84 152.8 21.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.912 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.0 m -57.99 156.98 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.323 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -132.78 151.49 51.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.7 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.88 127.44 9.25 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 60' ' ' LEU . 5.1 tt -61.08 -50.8 82.9 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.765 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 -69.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.676 1.584 . . . . 0.0 114.229 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.1 mmt -142.81 16.92 1.97 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.84 54.93 5.75 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.276 0.56 . . . . 0.0 110.294 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.19 98.04 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.674 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.37 -42.78 8.33 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.816 0.341 . . . . 0.0 111.29 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.01 97.99 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.06 -40.39 98.45 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -64.18 -41.14 97.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.341 0.115 . . . . 0.0 111.178 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 83' ' ' LEU . . . -101.14 134.93 43.42 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.56 149.0 46.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.708 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -86.59 120.53 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.358 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 ttm -136.08 99.72 4.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.95 137.9 58.3 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.041 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -80.47 177.09 9.23 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.574 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.3 p -71.08 -21.17 62.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.293 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.2 m -63.75 -39.06 93.35 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.672 0.272 . . . . 0.0 110.325 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 43.12 27.48 0.12 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.074 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -108.5 53.64 0.68 Allowed 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.486 0.66 . . . . 0.0 110.255 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 1.21 88.87 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.149 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -87.58 140.02 29.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.823 0.311 . . . . 0.0 110.552 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.74 152.03 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.349 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -137.64 142.1 41.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.215 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.949 HD11 ' HB1' ' A' ' 69' ' ' ALA . 56.0 tp -103.78 122.39 45.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.792 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -90.02 114.35 26.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.039 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -116.39 119.21 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.857 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.524 ' N ' HD13 ' A' ' 85' ' ' ILE . 47.2 ptt85 -85.77 151.37 23.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 59.81 57.13 3.25 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.926 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG21 HG11 ' A' ' 115' ' ' VAL . 5.3 p -59.26 155.95 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.334 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.36 9.37 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.52 -37.19 51.64 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.249 1.966 . . . . 0.0 113.125 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.3 p -61.98 -32.66 73.14 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.809 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -64.65 -35.7 81.88 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.688 0.28 . . . . 0.0 110.623 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -49.19 126.74 13.37 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.243 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.77 -157.48 26.33 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -112.97 153.21 28.39 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.65 0.262 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -130.72 139.34 50.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.817 179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -89.68 123.98 34.19 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.587 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 5' ' ' VAL . 50.3 t -99.77 110.74 23.11 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.43 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -105.06 134.77 47.6 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.107 0.563 . . . . 0.0 110.878 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -114.81 116.88 29.31 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -110.61 132.34 54.27 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.071 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -156.38 132.8 10.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.912 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -128.59 43.11 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.05 12.55 35.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.26 141.84 51.62 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.66 0.267 . . . . 0.0 111.691 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -148.96 160.07 43.63 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.542 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -148.65 145.62 27.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -138.86 145.46 40.01 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 5' ' ' VAL . 60.1 p -141.91 148.2 38.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.923 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.8 p -83.81 160.26 21.23 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.496 HG13 ' OD1' ' A' ' 9' ' ' ASN . 66.8 t -136.72 151.3 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.187 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.92 122.01 37.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.1 HD22 HD23 ' A' ' 22' ' ' LEU . 1.7 mp -133.57 117.57 17.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.848 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -120.63 104.21 9.75 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.953 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.79 HG11 HG21 ' A' ' 88' ' ' VAL . 35.9 m -87.78 137.1 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.216 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.14 141.35 54.64 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.446 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.857 -179.858 . . . . . . . . 0 0 . 1 stop_ save_